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Hsp70s are one of the most well conserved protein families known, yet little of their in vivo 
activity is understood and experimental resources required to investigate their activity. All 
Hsp70s are made up of two highly conserved functional domains joined by a flexible linker, 
the nucleotide binding domain and the substrate binding domain. The Hsp70 proteins 
undergo a conformational in their peptide binding and release cycle, with conformation of 
the protein determined by the nucleotide bound in the nucleotide binding domain. This study 
compared the two most wildly studied Hsp70 proteins, DnaK and the human Hsc70, HSPA8. 
Hsc70 is a constitutively expressed member of the Hsp70 family which has many roles 
within the cell, assisting with folding of nascent polypeptides, targeting proteins for 
degradation and translocating proteins to the endoplasmic reticulum. Both proteins were 
purified from bacterial expression systems and the purification of Hsc70 was improved by 
the addition of an additional isocratic step during ion exchange chromatography. Efficiency 
of labelling with fluorescent dyes was improved and the activity cycle of DnaK and Hsc70 
directly compared. Of the eight variants tested only two, DnaK variant C16S/K321C/E430C 
and Hsc70 variant E318C/T427C/C574S/C603S showed changes in FRET efficiency in 
response to different nucleotides. In order to validate these variants as suitable models and 
to probe why other variants showed no changes in FRET efficiency, proteins were analysed 
for their protein refolding activity. An improved luciferase refolding assay was developed 
to analyse the rate of protein refolding for each of the Hsc70 and DnaK variants. All of the 
variants for both DnaK and Hsc70 retained protein refolding activity, however most were 
less efficient than the wild type protein, showing between 20 to 100% of the wild type 
proteins activity. This study identified Hsc70 variant E318C/T427C/C574S/C603S as a 
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Chapter One: Introduction 
1.1 Molecular chaperones and Hsp70s 
1.1.1 Molecular chaperones 
Proteins are the most functionally versatile and structurally complex biological 
macromolecules, with millions of proteins being expressed in each cell (Milo, 2013). 
Proteins folding is a complex and intricate process in which de novo and denatured 
polypeptide sequences fold to form their functionally active conformations or states. Most 
proteins require a transition from the randomly coiled state formed after being translated to 
a specific three-dimensional conformation to perform their designed function. Although it 
has been shown that the amino acid sequence of the protein encodes the overall structure of 
the protein and that small, single domain proteins will fold into their native structure in vitro 
(Anfinsen, 1973), larger multi-domain proteins fold ineffectively. Hydrophobic forces are 
important for the folding of proteins and proteins larger than 100 amino acids undergo rapid 
hydrophobic collapse into compact conformations (Dill et al., 1995) to become more 
thermodynamically stable. The unfolded protein has many different pathways which it can 
follow to more thermodynamically stable states, yet not all lead to the native state (Hartl et 
al., 2011) (Figure 1). 
Figure 1:  Energy landscape of protein folding. The ruggedness of the free-energy 
landscape leads to the formation of folding intermediations which need to overcome energy 
barriers to reach the native state. Chaperone proteins help to reduce the energy barriers while 
also preventing the progression to a misfolded state.  
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 The protein folding energy landscape shows how for larger polypeptides some 
intermolecular contacts can form stable oligomers, amorphous aggregates or amyloid fibrils.  
In cells, the tendency of non-native state proteins to aggregate is increased drastically due 
to the high local concentration of nascent chains and the added effect of molecular crowding, 
when compared to folding in a dilute in vitro solution. Therefore, understanding how this 
transition from unfolded protein to the native states occurs within the highly complex and 
molecularly dense environment of cells remains a fundamental question in cellular biology.  
The proteome is controlled by a process called proteostasis, which manages the refolding of 
denatured proteins and the degradation of damaged proteins back into their molecular 
building blocks. This process is controlled by a large integrated molecular network of 
proteins with functions that range from de novo folding to proteolysis. This network is made 
up primarily by molecular chaperones and their regulators which bind to nascent and 
denatured proteins and counteract the aggregation of non-native states during both de novo 
folding and in response to stress conditions. Molecular chaperones are proteins which 
interact with or help another protein acquire its functionally active state but are not present 
in its final structure. There are several different chaperone protein families which are 
classified by their molecular weight and conserved structure and sequences with three 
families (HSP70s, HSP90s and the chaperonins) involved in de novo protein folding and 
refolding.  
Heat shock proteins (HSP) are a ubiquitously expressed family of molecular chaperones 
which are greatly upregulated in response to heat stress conditions. The function of this 
family has a large overlap with other molecular chaperones so are not highly expressed in 
normal conditions. At elevated temperatures, the rate of denaturation of proteins increases 
with most human proteins denaturing above 41°C so this family of proteins is expressed 
after heat shock to prevent the denaturation of proteins and assist in the refolding of the 
proteins which are denatured. These proteins promote folding through ATP- and cofactor-
regulated binding and release cycles and typically bind to hydrophobic amino-acid side 
chains or unstructured backbone regions in the unfolded polypeptides. These areas are 
typically exposed in non-native proteins and buried in the completed native state. These 
structural features are also prone to aggregation, which provides chaperones the opportunity 
to prevent the formation of aggregates via intermolecular binding of hydrophobic states. 
Chaperones can bind to hydrophobic residues up to every 40 residues during de novo 
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folding, stabilizing the polypeptide as it emerges from the ribosome in the extended 
conformation (Rudiger et al., 1997).  
1.1.2 Hsc70 chaperone 
The HSP70 system is a family of approximately 70 kilodalton proteins which are present in 
all life forms and most cellular compartments of eukaryotes, being one of the most highly 
conserved protein among all organisms on earth. HSP70 proteins interact transiently with a 
broad spectrum of polypeptides, associating with 15-20% of newly synthesised protein 
(Teter et al., 1999) ranging from 14 to upwards of 90 kilodaltons, preferentially interacting 
with polypeptides between 30-75 kilodaltons. These interactions occur co-translationally 
and post-translationally with most polypeptides interacting and leaving rapidly as they 
require little folding assistance. Other proteins will interact for a longer period of time, 
reflecting their slower rate of intrinsic folding and lower intrinsic stability hence the need 
for greater chaperone assistance. DnaK is the major bacterial Hsp70 which is shown to 
associate with roughly 10% of all soluble polypeptides, with trigger factor (ribosome 
associated protein) determining the substrate specificity of the protein (Valent et al., 1995).  
Hsc70, heat shock cognate protein 70, is a member of the Hsp70 family found in humans 
that is constitutively expressed in all cell types. It is a major cytosolic molecular chaperone 
which is particularly abundant in embryos and ovaries, greatly exceeding the levels of actin 
and tubulin. It is highly conserved with Hsc70 proteins from humans, rats and hamsters 
having a 99% amino acid sequence identity. It shares 85% amino acid similarity with Hsp70, 
with most of the differences occurring in the C-terminal domain of the protein which is 
primarily involved in substrate specificity. The stress response is significantly different 
between Hsc70 and Hsp70 with the constitutively expressed Hsc70 only being mildly 
upregulated under heat shock conditions whilst Hsp70 is highly inducible and is upregulated 
during stress conditions. Like all other members of the HSP70 family it has roles in protein 
maturation and folding, but it also has a role in un-coating of clathrin vesicles and 
translocation of proteins into the endoplasmic reticulum. Hsc70 is associated with an 
extensive number of cancers as it allows cancer cells to survive under proteotoxic stress by 
preventing Rab1A degradation (Tanaka et al., 2014), as well as preventing 
neurodegenerative and many other diseases as it is an important regulator of protein folding 
(Liu et al., 2012). Understanding the functions and interactions of Hsc70 could lead to 
possible therapeutic targets and novel drug discovery, as well as the potential for the 
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utilization of Hsc70 as a biomarker for disease. In order to properly understand function of 
the protein it is crucial to understand the both the structure and dynamics of the protein and 
how it interacts with different substrates. 
1.2 Structure and movement of domains  
Hsp70 proteins have three different domains, a nucleotide binding domain (NBD), substrate 
binding domain (SBD) and a C-terminal domain. The C-terminal domain is an inherently 
disordered 10 kDa carboxyl-terminal domain which is also designated as the variable or 
“lid” domain which is primarily involved in substrate specificity. The end of the C-terminal 
domain has amino acid sequence Glu-Glu-Val-Asp (EEVD motif), which is absolutely 
conserved in all eukaryotic Hsc70 and Hsp70 family members and is essential for both 
ATPase activity and association with J-domain co-chaperone interaction (Freeman et al., 
1995). The two functional domains, the N-terminal nucleotide binding domain (NBD) and 
a substrate binding domain (SBD) connected by a highly-conserved linker flexible linker. 
The NBD is a 44 kDa ATPase domain consists of four α-β subdomains which are split into 
two separate lobes surrounding a central ATP binding cleft. The NBD determines affinity 
and peptide association/dissociation rate of the heat shock protein to its polypeptide 
substrate, changing depending on the nucleotide bound. The SBD domain is an 18 kDa 
substrate (peptide) binding domain sub-divided into a β sheet subdomain (SBDβ), which 
contains the peptide binding pocket, and an α-helical subdomain (SBDα).  
DnaK has been used as a model for Hsc70 however there is some doubt whether the two 
proteins behave exactly the same way. For DnaK, both functional domains, the NBD and 
SBD, have been crystallised separately in bound and free states (Zhu et al., 1996; DeLuca-
Flaherty et al., 1988). The full-length protein has been difficult to crystalize due to the highly 
flexible nature of the linker region between the NBD and SBD as well as the inherently 
disordered C-terminal domain. DnaK has been crystalized in the presence of both ATP 
(Kityk et al., 2012) and ADP (Bertelsen et al., 2009), and can be seen in Figure 2. A crystal 
structure of a functionally intact Hsc70 was published in 2005 (Jiang et al., 2005) however 
the protein lacked the highly flexible 10 kDa C-terminal domain which may affect the in 
vivo structure. Two other methods have been used to visualise the full protein which deal 
with the more dynamic nature of the protein, nuclear magnetic resonance (NMR) (Bertelsen 
et al., 2009) and small angle X-ray scattering (SAXS) (Shi et al., 1996; Wilbanks et al., 
1995). The results from the NMR suggested that the NBD and SBD domain are loosely 
5 
 
linked by a dynamic random coil, and that the SBD is in close proximity to the subdomain 
IA of the NBD suggesting this area can establish allosteric communication. The SAX data 
also indicated that there was movement between the domains, indicating a conformational 
change depending on nucleotide state. The data also suggested that both the bacterial DnaK 
and the human Hsc70 formed oligomeric states, however the DnaK formed multimeric 
oligomers whilst the Hsc70 dimerised. 
Figure 2: Cartoon representation of nucleotide dependent Hsp70 conformational changes. 
Panel A shows DnaK in the extended, ADP bound state (Bertelsen et al., 2009). Panel B shows the 
crystal structure of DnaK with ATP bound (Kityk et al., 2012). In both panels the NBD is shown in 
green and the SBD and C-terminal tail shown in red with α-helices shown as spirals and β-sheets 
shown as arrows. 
ATP hydrolysis is essential for Hsp70 chaperone function and this ATPase activity is 
stimulated by protein substrates in synergy with J domain cochaperones. Although the SBD 
and NBD can each bind independently, chaperone activity requires tight coupling of the two 
domains. This coupling ensures efficient energy use in the Hsp70 family through a mutual 
allosteric control mechanism. The SBD undergoes significant conformational changes when 
ATP or ADP is bound with α and β subdomains separating when ATP is bound, allowing 
for release of the polypeptide, or closing when ADP is bound. This conformational shift 
facilitates the binding and release of the substrate, with the bound substrate released to either 
finish folding or to enter another round of the chaperone cycle. When ADP is bound, the 
protein is in the extended conformation, with the SBD and NBD separated and the lid of the 
substrate binding domain closed. This allows for the dissociation of the ADP and the binding 
of ATP in the NBD which induces an opening of the polypeptide binding channel in the 
SBD and the NBD and SBD coming back together (Qi et al., 2013). In the ATP conformation 
the lid is opened and makes multiple contacts with the NBD, allowing for the binding of 
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substrates. It has been shown in DnaK, that this conformation can also be assumed in the 
nucleotide-free state (Kityk et al., 2012) which is consistent with previous studies that 
indicate that all nucleotide states have both “open” and “closed” conformations in different 
proportions (Marcinowski et al., 2011; Schlecht et al., 2011). 
The current consensus in the literature indicates that Hsc70 and DnaK inhabit two different 
conformational states (Figure 2), the open conformation primarily seen with ATP bound or 
the closed conformation with ADP bound or in the nucleotide free state (Qi et al., 2013). 
This model is applicable to all Hsp70 chaperones however, there are conflicting reports in 
the literature when comparing the ADP states of different HSP70 chaperones specifically 
mammalian Hsc70 and bacterial DnaK. In mammalian Hsc70 (intact bovine Hsc70) there 
appears to be extensive interdomain interactions critical for chaperone function between the 
NBD and SBD helix A and that there is an allosteric mechanism in which the interdomain 
linker invades and disrupts the interdomain interface upon ATP binding (Jiang et al., 2005). 
This contrasts to the data for DnaK which indicated that the NBD and SBD were found to 
behave independently in its ADP bound form and that the two domains are also mobile in 
wild type DnaK (Bertelsen et al., 2009). It is likely that Hsc70 does not behave exactly like 
DnaK, so gathering structural information on the conformational change in Hsc70 could 
shed more light on how Hsc70 functions. 
1.2.1 Mechanism of protein refolding  
There are two mechanisms by which HSP70s are thought to increase the efficiency of 
substrate refolding (Mayer and Bukau, 2005). The first mechanism is the sequestering 
function were the HSP70 regulates the amount of free unfolded polypeptides, reducing the 
opportunity for hydrophobic regions to aggregate thus enabling free proteins to fold 
undisturbed. The second mechanism that increases the efficiency of substrate refolding is 
that the binding and release cycle changes the energy landscape of folding reducing kinetic 
obstacles between different folded states by physically inducing changes to misfolded local 
structures. Both of these mechanisms will increase the total yield of correctly folded 
proteins, the sequestering function leading to an increase in the yield for proteins requiring 
greater levels of assistance whilst lowering energy barriers could increase both the overall 
yield and the efficiency of protein folding.  
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During the folding of substrate peptides, the Hsc70/peptide complex goes through a number 
of ATP-dependent binding and release cycles, mediated by a number of cochaperones 
(Figure 3). The NEF (nucleotide exchange factor) and J-domain cochaperones regulate the 
ATPase cycle of the protein, accelerating the ATP hydrolysis and the dissociation of ADP 
as well as providing substrate specificity. In bacterial cells the main chaperone DnaK mainly 
associates with two cochaperones, GrpE (a NEF) and DnaJ (a J-domain protein), whereas 
human Hsp70s have many different co-chaperones in order to carry out all of the functions 
required in the eukaryotic cell, each with varying affinities and specificities (Yu et al., 2015).  
Figure 3: HSP70 protein peptide binding and release cycle. DnaK/Hsc70 represented by the green 
(NBD) and red (SBD) symbol. The J domain cochaperone is represented as a brown symbol and the 
nucleotide exchange factor in yellow. The polypeptide substrate is shown in black as either a 
unfolded sequence (extended line) or as a folded protein (circle).  
It has been shown that in E. coli DnaK cochaperones acted sequentially on the ATPase cycle 
with GrpE stimulating nucleotide exchange and DnaJ forming direct interactions with the 
substrate as well as stimulating the DnaK folding activity (Langer et al., 1992). As 
mentioned earlier J-domain proteins provide substrate specificity as well as stimulating ATP 
hydrolysis and this point is emphasised when comparing the number of isoforms in humans. 
There are 11 Hsp70 isoforms which corresponds with 13 nucleotide exchange factors, in 
contrast to this there are currently 41 identified J-domain proteins, recognised by a conserved 
~70 residue domain. Because the HSP70 binding and release cycle has primarily been 
studied using DnaK as a model and there is contention on whether DnaK interacts in the 
same way as Hsc70, investigating the Hsc70 protein peptide binding and release cycle and 
conformational shift may provide insights into how the protein funtions. 
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1.3 Fӧrster resonance energy transfer as a reporter of protein dynamics  
Fӧrster resonance energy transfer (FRET) is the non-radiative transfer of energy from a 
donor to an acceptor fluorophore over a short distance typically between 10 and 100 Å (1-
10 nm). The transfer of this energy relies on the emission spectra of the donor fluorophore 
and the excitation spectra of the acceptor fluorophore overlapping. The efficiency of the 
transfer relies on the spectral overlap as well as the distance and orientation of the donor and 






used, where R is equal to the distance between the two fluorophores and R0 is equal to the 
Fӧrster distance at which E = 0.5 for the donor acceptor pair used. The R0 accounts for the 
spectral overlap and the orientation for each FRET molecule and differs between different 
FRET pairs. This dependence of the efficiency of the transfer on the inverse of the sixth-
power distance means that minor changes in the distance between the fluorophores can give 
rise to significant changes in FRET efficiency when the distance between fluorophore is 
close to the R0 (Figure 4). This sensitivity to slight changes in distance makes FRET a useful 
tool for monitoring protein dynamics such as changes in conformation.  
Figure 4: FRET efficiency as a function of distance between fluorophores. This graph 
shows the FRET efficiency of the donor and acceptor pair AlexaFluor 488 and AlexaFluor 
594 in response to distance separation, R0 = 60 Ångstroms.  
Monitoring protein dynamics is an important part of understanding how proteins function 
and interact with substrates. In crystal structures the protein is visualized as a stationary 
molecule with definitive shape and interactions, however most proteins are dynamic 
9 
 
molecules and will occupy a number of different shapes in vivo. Being able to detect all of 
the different conformations that the protein occupies is key to fully understanding how the 
protein functions. Ensemble FRET has been used in biochemistry to measure and detect the 
molecular interactions in a number of systems and can be used to measure the distances 
between domains within a single protein or to detect interactions between proteins. This tool 
can therefore be used to track the movement of protein domains relative to each other so can 
detect conformational changes for proteins.  FRET experiments have been used to study the 
dynamics of many different proteins, including the mitochondrial form of human Hsp70 
(mtHsp70) (Mapa et al., 2010).  In their study Mapa et al. used FRET to show that both the 
hydrolysis of ATP to ADP and the presence of substrate were required to completely undock 
the NBD and SBD domains during protein binding and release. These authors also found 
that when ADP is bound the protein was more flexible with broad distance distributions for 
both domain-domain interactions as well as the conformation of the SBD. Another recent 
study bound pairs of Alexa Fluor dyes to the SBD lid subdomain of DnaK and showed that 
the lid formed at least two distinct conformations when ADP is bound, yet the ATP bound 
state was shown to be homogeneous (Banerjee et al., 2016).  They also found that the 
cochaperone DnaJ accelerates the substrate binding rate of the protein as well as conferring 
conformational heterogeneity similar to the ADP-bound states. Single molecule FRET 
analysis on DnaK variants has also shown that the protein visits multiple conformations and 
that the nucleotide influences the occupancy of these conformations (Walsh, 2012). These 
results all differ from previous models which suggest two distinct states when ATP or ADP 
are bound, rather than the relative freedom suggested by these studies. Ensemble FRET on 
an active variant will be able to detect any changes of conformational state in response to 
nucleotide bound as it measures the average distance for all of the sample in a given solution. 
By measuring the changes in FRET the relative occupancies of each state can be determined. 
1.4 Cysteine variants, design pairing  
In this project, the protein conformational change of DnaK and Hsc70 is visualised using 
the Alexa Fluor dye pair of AF 488 and AF 594 bound to the protein at specific cysteine 
residues. To bind the dyes to designed residues both proteins were mutated so that the dyes 
bound consistently to places designed show a FRET change in response to a conformational 
shift. Alexa Fluor dyes react with reduced cysteine residues to form thioester bonds, so in 
order to bind Alexa Fluor dyes onto DnaK and Hsc70 cysteine variants were introduced into 
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the protein. Firstly, the cysteine residues in the wild type protein were mutated to serine 
residues so that there were no unintended sites for the Alexa Fluor dyes to bind. In DnaK 
one mutation was made C16S and in Hsc70 two residues in the C-terminal domain were 
mutated (C574S and C603S), these mutations were present in all of the variants tested.  
When designing the mutants for FRET analysis of the two sites on each of the substrate 
binding domain and the nucleotide binding domain were targeted to form variant pairs. Sites 
were chosen to be on the surface of the protein domains so that there was as little interference 
from quenching as possible, as well as being accessible to the dyes when labelling. When 
designing residue pairs for mutation two crystal structures were used, the first 2KHO which 
shows E. coli DnaK (1-605) complexed with ADP and substrate (Bertelsen et al., 2009) and 
the second 4B9Q which shows E. coli DnaK (1-605) in the open ATP-bound conformation 
(Kityk et al., 2012). For FRET assays DnaK mutants were generated using either the 
mutation N254C or K321C in the nucleotide binding domain paired with either E430C or 
R517C in the substrate binding domain. The mutations on the substrate binding domain are 
positioned so that there is a thiol on either the α-helical lid and the β-sheet substrate binding 
sub domains. In order to analyse the Hsc70 protein through FRET analysis equivalent 
mutations were made, matching each of the mutations made in DnaK. The Hsc70 protein 
sequence was modelled against the DnaK structures 2KHO and 4B9Q using ClustalW, to 
determine which residues most closely aligned to those in DnaK. Using this tool, the 
following residues were mutated to cysteines by Malcolm Rutledge (MSc Thesis) to match 
each of the mutants made in DnaK; E255C to N254C, E318C to K321C, T427C to E430C 
and Q520C to R517C. 
1.5 Luciferase refolding assay 
There are two commonly used protocols to determine whether the protein has been 
compromised by either the mutation or the subsequent labelling process. The first technique 
tests the ability of the protein to undergo conformational change by testing its ability to 
refold denatured protein in the luciferase refolding assay. This is a comprehensive test of the 
protein as it not only tests the variants ability to change conformation investigates how 
effectively the protein functions. This technique utilizes the bioluminescent properties of the 
protein firefly luciferase and the poor rate of intrinsic refolding to determine how much 
refolding activity the chaperone variants have. The firefly luciferase protein will convert its 
substrate molecule luciferin into emitted light at a constant rate when in its functional state. 
11 
 
Previous chaperone studies have utilized this protein, with the commonly used method 
involving a two-pot experimental technique where chemically denatured protein is first 
refolded in a refolding buffer containing chaperones and associated cochaperones then 
samples were periodically tested for luciferase activity in a separate reaction mixture 
(Gestwicki and Wisén, 2008). Another study utilised the firefly luciferase protein to monitor 
the refolding activity in response to various chaperone systems from various sources 
(Groemping et al., 2001). These authors used a continuous assay containing chaperones and 
the luciferin substrate and measured change in luminescence over a period of 500 minutes.  
The second technique used to determine whether the chaperone protein has been 
compromised is to subject the protein to limited proteolysis in different nucleotide states. In 
this technique, the sample is incubated with proteinase K for a limited period of time then 
precipitated by adding Trichloroacetic acid/acetone. The protein was then resuspended and 
analysed by SDS-PAGE. This process leads to the sample only being partially digested and 
the proportion un-cleaved protein and different fragments under each nucleotide bound state. 
The different nucleotide states are then compared to the wildtype protein to see if the 
conformation of the protein is nucleotide dependent and that the same fragments are present.  
The susceptible region of DnaK/Hsc70 to endopeptidase attack is the linker region which is 
exposed in the ADP bound state but hidden in the ATP state so if a conformational shift does 
occur there should be a noticeable difference between the states with the ATP having less 
cleaved protein. This analysis was carried out by another member of the lab (Malcolm 
Rutledge, 2016), with all of the variants displaying the ability to change conformation in 










1.6 Aims for Masters 
The overall goal of this study was to prepare a Hsc70 FRET reporter which can be used in 
future studies of Hsc70 function and to test the strength of DnaK as a Hsc70 model. In order 
to achieve this goal three aims were established. 
1. To express and purify Hsc70 and DnaK variant proteins modified for FRET 
labelling.  
2. To label and measure the FRET efficiency and response to nucleotide for each of the 
Hsc70 variants.  
i. The Hsc70 variants were compared to the homologous variants in DnaK to 
monitor how well DnaK modelled Hsc70.  
3. Test the functional activity of each DnaK and Hsc70 variant 
i. A modified luciferase assay was developed to test protein refolding 
ii. Refolding response in relation to protein concentration was examined to view 
changes between DnaK and Hsc70 variants. 
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Materials and Methods 
Specialised equipment 
ÄKTAprime plus purification system (GE Healthcare) 
ÄKTA pure 25 purification system, Fraction collector F9C, Sample pump S9 (GE 
Healthcare) 
Avanti J-26 XP Centrifuge, with JA.17 and JLA 8.1 rotors (Beckman Coulter) 
Biological HR Workstation, Biologic HR controller and Model 2128 Fraction collector 
(BioRad) 
Branson sonifier cell disrupter (Branson Ultrasonics) 
Cary 50 Bio UV-visible spectrophotometer (Varian) 
Cary Eclipse fluorescence spectrophotometer (Varian) 
CLARIOstar plate reader, Firmware version 1.10 (BMG Labtech)  
Eppendorf centrifuge 5810 R (Thermo Fisher Scientific) 
Gel Doc 2000TM (BioRad) 
Image Scanner III (GE Healthcare) 
Microfuge® 16 centrifuge (Beckman coulter)  
Nanodrop ND-1000 Spectrophotometer (Thermo Fisher Scientific) 
Vacuum pump V-700 (Global sciences) 
Columns and chromatography 
Adenosine 5’-triphosphate-agarose on a C-8 linkage with a nine-atom spacer (Sigma-
Aldrich) used in a 1.1 cm diameter, 10 cm long Ace Glass column (Ace Glass) 
DEAE-Sepharose Fast Flow (Amersham Biosciences – subsidiary of GE Healthcare) used 
in a 2.5 cm diameter, 25 cm long Ace Glass column (Ace Glass) 
Superdex® 200 HiLoad® 26/600 gel filtration column (Pharma Biotech – subsidiary of GE 
Healthcare) 
HiPrep 26/10 desalting column (Amersham Biosciences – subsidiary of GE Healthcare) 
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PD-10 desalting columns (GE Healthcare) 
NAP-5 desalting column (GE Healthcare) 
Solutions 
Growth media 
Lysogeny broth (LB) media: 1% w/v bacto-tryptone, 0.5% w/v yeast extract, 1% w/v NaCl, 
Milli-Q. For agar plates 1.5% w/v bacto-agar was added. Amp (50 µg.mL-1) and Chlor 
(25 µg.mL-1) were added where appropriate.  
2× Yeast extract and Tryptone (2x YT) media: 2% w/v bacto-tryptone, 1% w/v yeast extract, 
0.5% w/v NaCl 
Terrific broth (TB) media: 1.2% w/v bacto-peptone, 2.4% w/v yeast extract, 0.4% v/v 
glycerol, 17 mM KH2PO4, 72 mM K2HPO4, 2 mM MgSO4 
 
SDS-PAGE gel electrophoresis 
5× SDS denaturing loading buffer: 60 mM Tris-HCl (pH 6.8), 25% v/v glycerol, 2% w/v 
SDS, 14.4 mM β-mercaptoethanol, 0.1% w/v bromophenol blue 
4× stacking gel buffer: 1.5 M Tris-HCl (pH 8.8), 0.4% w/v SDS, Milli-Q 
4× resolving gel buffer: 0.5 M Tris-HCl (pH 6.8), 0.4% w/v SDS, Milli-Q 
10× SDS-PAGE Electrophoresis buffer: 250 mM Tris, 1.92 M glycine, 1% w/v SDS, 
pH ~8.3  
Coomassie Gel stain: 25% v/v isopropanol, 10% v/v glacial acetic acid, 0.05% w/v 
Coomassie Blue R-250, Milli-Q 
Coomassie Gel destain solution: 5% v/v isopropanol, 7% v/v glacial acetic acid, 4% v/v 
glycerol 
DnaK/Hsc70 purification 
All stock solutions were prepared with Milli-Q water and autoclaved unless otherwise 
specified, all working buffers were filtered through a 0.2 µm filter under a vacuum pump 
into autoclaved glass ware. If used for chromatography all working solutions were degassed 






Lysis buffer/DEAE anion exchange Low salt buffer: 20 mM Tris-HCl (pH 6.9), 50 mM 
NaCl, 100 µM EDTA,100 µM PMSF 
DEAE anion exchange high salt buffer: 20 mM Tris-HCl (pH 6.9), 1.0 M NaCl, 100 µM 
EDTA, 100 µM PMSF 
EDTA Dialysis buffer: 20 mM Tris-HCl (pH 6.9), 150 mM KCl, 4mM EDTA 
ATP-agarose low salt buffer: 20 mM Tris HCl (pH 6.9), 25 mM KCl, 3 mM MgCl2 
ATP-agarose high salt buffer: 20 mM Tris HCl (pH 6.9), 1.0 M KCl, 3 mM MgCl2 
ATP-agarose elution buffer: 20 mM Tris HCl (pH 6.9), 25 mM KCl, 3 mM MgCl2, 
3mM ATP 
Gel filtration buffer: 20 mM HEPES (pH 7.6), 100 mM KCl, 5 mM MgCl2 
Buffer for labelling with fluorophores: 50 mM Tris-HCl (pH 8.5), 100 mM KCl, 0.5 mM 
EDTA, 1 mM MgCl2, 10% v/v glycerol, Milli-Q 
PD-10 wash buffer: 20% v/v Ethanol, 100 mM Sodium Acetate, Milli-Q 
Luciferase refolding 
Firefly luciferase denaturation buffer: 6 M guanidine hydrochloride, 25 mM HEPES 
(pH 7.2), 50 mM Potassium acetate, 5 mM DTT, Milli-Q  
Glycine buffer: 50 mM glycine, 30 mM MgSO4, 10 mM ATP, 4 mM DTT, Milli-Q, pH 7.8 
SteadyGlo reagent: Diluted in glycine buffer with 10% SteadyGlo. 
Firefly luciferase Refolding mix:  75 mM KOAc, 50 mM glycine, 30 mM MgSO4, 10 mM 
ATP, 4 mM DTT, 12 mM creatine phosphate, 50 U.mL-1 creatine phosphokinase, 2% 
SteadyGlo reagent (Chang et al., 2010). For DnaK, protein variants were added to desired 
concentrations (0.5, 1 and 2 µM) with 48 nM DnaJ and 24 nM GrpE. For Hsc70 protein 



































Competent cell preparation  
Using aseptic techniques cells were streaked from glycerol stock onto an LB plates 
containing the appropriate antibiotic then incubated at the appropriate growth temperature 
overnight. A single colony was picked from the plate and 3 mL of LB containing antibiotic 
was inoculated and incubated overnight. Fifty mL of 2× YT media inoculated with 500 µL 
of O/N culture was incubated until OD600 = 0.6. The culture was transferred to an ice cold 
50 mL tube and centrifuged at 4°C for 5 min at 3,220 g. The supernatant was discarded and 
the pellet was resuspended in 25 mL ice cold 50 mM CaCl2. The resuspension was incubated 
on ice for 30 min and then centrifuged at 4°C for 5 min at 3,220 g. The supernatant was 
discarded and pellet resuspended in 4 mL 50 mM CaCl2 containing 20% v/v glycerol. 
Competent cells were aliquoted (200 µL) into pre-cooled tubes and then snap frozen in 
methanol + dry ice and stored at -80°C.  
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein samples were prepared for analysis via SDS page by mixing with 5× denaturing 
loading buffer. SDS-PAGE gels were made up to 12.5%. SDS-PAGE gels were prepared 
and run as per the methods in Bollag et al. (1996) with BioRad broad-range molecular weight 
marker used to identify the molecular weight of the protein. The marker was diluted 1/20 in 
1× denaturing buffer and aliquoted into 5 µL samples so that each band of the marker was 
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equal to 500 ng on the SDS-PAGE gel. Gels were interpreted following Coomassie Blue 
staining and imaged on an Image Scanner III (GE Healthcare).  
Calculation of protein concentration 
Protein concentration of Hsc70 and DnaK was determined through two different methods, 
tryptophan absorbance at 280 nm and densitometry of Coomassie stained SDS-PAGE gels. 
To determine the protein concentration via tryptophan absorbance at 280 nm samples were 
analysed on a NanoDrop ND-1000 spectrophotmeter using the Beer-Lambert equation A = 
ε.c.l, where A is the absorbance at 280 nm, ε is the extinction co-efficent in mM-1.cm-1, c is 
the concentration of the protein in mol.L-1 and l is the path length of light through the sample. 
The extinction coefficient (ε) of DnaK is 24,200 mM-1.cm-1 (Rogawski, 2010) and of Hsc70 
is 33,600 mM-1.cm-1 (calculated on Expasy Protpram based on sequence) and they are 
69.114 and 70.898 kDa respectively.  
Due to the low levels of tryptophan present in the protein the A280 reading was not able to 
give reliably accurate concentrations of protein but was useful for initial estimates. 
Densitometry was used to get more accurate concentrations of proteins and to calculate the 
relative purity of the protein. Densitometry uses images from SDS-PAGE gel analysis to 
calculate the relative intensity of each protein band. Protein concentration and purity dilution 
series on SDS-PAGE gels were analysed using one of two programmes, Image-J and Image 
Studio Lite (Ver 3.1). The marker at the appropriate molecular weight (66 kDa) was 
compared to protein bands of similar intensity to quantify the concentration of the protein 
as they are equal to 500 ng. 
Transformation of DH5α 
Two hundred microlitre aliquots of CaCl2 treated competent cells were aliquoted into 2x 
50 µL samples and a 100 µL sample. One µL or approximately 100 ng of the desired plasmid 
was added to the 50 µL aliquots of ultra-competent E. coli strain DH5α cells and then rested 
on ice for 30 min. Cells were heat-shocked at 42°C for 45 s then rested on ice for 2 min. One 
millilitre of autoclaved LB was added to each sample and incubated at 37°C for 60 min. 
Cells were centrifuged for 10 minutes at 12,000 g and the supernatant was discarded. Cells 
were gently resuspended in 100 µL of autoclaved LB. Cells were plated onto LB agar plates 
containing 30 µg.mL-1 chloramphenicol. Two controls plates containing no antibiotic and 
30 µg.mL-1 chloramphenicol and 25 µg.mL-1 kanamycin were used to ensure the correct 
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plasmid was incorporated and the cells were viable. Plates were incubated O/N at 37°C and 
then stored at 4°C.  
Plasmid purification  
Tubes containing 2× 3 mL LB + 25 µg.mL-1 ampicillin were inoculated with single colonies 
from plates using a sterilized tooth pick and grown O/N at 37°C with agitation. After O/N 
incubation cells were pelleted at 12,000 g for 5 min discarding the supernatant, plasmid was 
purified from the resulting cell pellet using an OMEGA mini plasmid prep kit following the 
manufactures protocol and guidelines (Omega, 2008). Purified plasmid was eluted into 30, 
50 or 100 µL samples and quantified with UV absorption at 260 nm on a Nanodrop ND-
1000 spectrophotometer.  
Protein purification 
Transformation of BB1553 (DE3)  
Two hundred microlitre aliquots of competent cells were aliquoted into 2× 50 µL samples 
and a 100 µL sample. 1 µL or approximately 100 ng of the desired pMSK (pRBH) variant 
was added to the 50 µL aliquots of competent E. coli strain BB1553 (DE3) cells and then 
rested on ice for 30 min. Cells were heat-shocked at 37°C for 45 s then rested on ice for 2 
minutes. One millilitre of autoclaved LB was added to each sample and incubated for 60 
min at normal growth temperature (28°C) on a shaker (~200 rpm).  Cells were then pelleted 
via centrifugation at 12,000 g and the supernatant was removed and cells were gently 
resuspended in 100 µL of autoclaved LB. Cells were plated onto 25 µg.ml-1 ampicillin and 
30 µg.ml-1 chloramphenicol plates and incubated at 28°C overnight then stored at 4°C. Two 
controls are performed to ensure the correct plasmid has been incorporated and the cells 
were viable. One of the 50 µL samples is plated onto 30 µg.mL-1 chloramphenicol and 
25 µg.mL-1 kanamycin and the 100 µL is plated onto 30 µg.mL-1 chloramphenicol. 
Transformed cells were selected using a sterilised toothpick to isolate single colonies then 




A single colony of BB1553 (DE3) containing the appropriate plasmid from a selective media 
agar plate was used to inoculate 5 mL of LB medium including selective antibiotics. 
Incubation proceeded overnight at 28°C on a shaker (~200 rpm). Following O/N incubation 
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the 5 mL culture was added to 500 mL LB broth in a 2 L baffled flask at 28°C containing 
selective antibiotics. When OD600 reached ≥ 0.3, ITPG was added to 400 µM then incubated 
overnight at 28°C. Cells were harvested and pelleted via centrifugation (5000 rpm, 20 min, 
4°C, JLA 8.1 rotor, Avanti-TM J-26 XP Centrifuge) then the pellet was weighed and either 
resuspended for purification immediately or stored at – 20°C. Pellet was resuspended in lysis 
buffer to a point at which a 1/40 dilution (20 µL in 800 µL) of the homogenized sample gave 
an OD600 of ≤ 1.2. Cells were lysed using a Branson Sonifier cell disrupter until a five-fold 
reduction in OD600 was achieved (Intensity 4, duty cycle 40%, pulse setting). Once cells 
were lysed cellular debris were removed via centrifugation in 30 mL vessels (20,000 g, 25 
min, 4°C, JA.17 rotor, Avanti-TM J-26 XP Centrifuge). Supernatant was pooled and passed 
through a syringe filter (0.2 µM filter). 
Column care and preparation 
All chromatography columns were stored in either Milli-Q plus 20% ethanol or 1 mM Na3N. 
Before and after applying running buffers all lines were rinsed with Milli-Q water. Columns 
were attached to the FPLC equipment drop to drop to prevent air bubbles forming in the 
column. The FPLC was also cleaned in place with 1 M NaOH and Milli-Q plus 20% ethanol.  
 Diethylaminoethyl cellulose (DEAE) column  
A DEAE-sepharose anion exchange column was equilibrated in one column volume (150 
mL) low salt buffer, one column volume high salt buffer and one column volume low salt 
buffer. Clarified lysate was added at 3 mL/min and the column was washed with 100 mL of 
low salt buffer to remove unbound protein. Elution of protein differed between Hsc70 
variants and DnaK variants. The column was cleaned with a 100 mL gradient from 60 to 
100% high salt gradient, followed by 250 mL of low salt buffer containing Sodium Azide 
(1 mM) for storage. All steps were run at 3 mL/min unless left for overnight equilibration. 
For DnaK protein was eluted over a 120 mL linear gradient from 0 to 60% high salt buffer 
collecting 20 mL fractions into 50 mL tubes. Elution of Hsc70 included a salt step at 
17mS.cm-1 (~100 mM NaCl) followed by a linear salt gradient to 60% high salt. Appropriate 
concentrations of high to low salt were calculated using the values from the equilibration as 
buffers would differ slightly in conductivity. SDS-PAGE gel electrophoresis was used to 




ATP agarose column 
ATP agarose column was equilibrated with at least one column volume (12 mL) of ATP 
agarose low salt buffer, one column volume of ATP agarose high salt buffer, one column 
volume of ATP agarose low salt buffer, one column volume of ATP agarose elution buffer 
and one column volume of ATP agarose low salt buffer.  The column was stored in ATP 
agarose low salt buffer containing Na3N (1 mM). The column was run at a rate of 2 mL/min.  
To prepare the protein for ATP affinity chromatography selected fractions were pooled and 
dialysed overnight at 4°C against 2× 1L of EDTA dialysis buffer with a charcoal bag. EDTA 
buffer removes the bound nucleotide from the protein and the charcoal binds to small 
molecules and improves the rate of dialysis (Spector, 1980). After dialysis 10 mM MgCl2 
was added to facilitate binding to the ATP column. The nucleotide binding domain of 
DnaK/Hsc70 can bind to the ATP group with high affinity (~1 µM dissociation constant). 
The protein was centrifuged in 30 mL vessels (20,000 g, 25 min, 4°C, JA.17 rotor, Avanti-TM 
J-26 XP Centrifuge) to remove aggregated and insoluble proteins and the supernatant was 
loaded onto the ATP-agarose column. The column was washed with one column volume of 
ATP agarose low salt buffer and one column volume ATP agarose high salt buffer prior to 
elution. DnaK/Hsc70 was eluted with 10 mL ATP agarose elution buffer followed by 15 mL 
of ATP agarose low salt buffer collected in 1 mL fractions. Fractions were analysed using 
SDS-page gel electrophoresis and those containing significant amounts of relatively pure 
DnaK/Hsc70 were pooled.  
Gel filtration column 
The HiLoad 26/600 Superdex 200 and Sephadex G-25 column are stored in Milli-Q plus 
20% ethanol and was equilibrated with 1 CV (320 mL) Milli-Q water followed by 400 mL 
of gel filtration buffer. After the samples were eluted the column was washed with 1 column 
volume Milli-Q then put into Milli-Q plus 20% ethanol for storage.  The column had a flow 
rate of 3 mL/min unless run overnight during equilibration in which case the flow rate was 
slowed to 0.1 mL/min to maintain a constant flow over the column. 
Pooled fractions from the ATP agarose column were separated by size exclusion 
chromatography over a HiLoad 26/600 Superdex 200 column. Pooled fractions were 
concentrated down to a maximum of 13 mL if necessary before being loaded onto the 
column. Eluate was collected from 80 to 400 mL post injection in 2.5 mL fractions. Fractions 
which showed absorbance at 280 nm were analysed by SDS-PAGE gel electrophoresis and 
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those containing significant amounts DnaK/Hsc70 were pooled and concentrated in a 
10 kDa MWCO concentrator. Protein was aliquoted and snap frozen in liquid nitrogen and 
stored at -80°C.  
Fluorescent labelling and analysis  
Fluorescent labelling  
DnaK and Hsc70 cysteine variants were labelled with fluorophores AlexaFluor488 (AF488) 
and AlexaFluor594 (AF594) for analysis with FRET. Introduced cysteines were reduced and 
formed thioester bonds with the fluorophores through a thiol-maleimide reaction (Wong et 
al., 2009).  
To prevent the cysteines residues being oxidised before the thioester bond can form all steps 
after the addition of the reductant were performed in a low oxygen environment. The 
labelling buffer was degassed thoroughly using a vacuum pump then aliquoted into 50 mL 
tubes for use. Each 50 mL tube had argon gas bubbled through it for 30 min before it was 
used in the protocol and all steps were carried out in a container filled with argon gas.  
Excess DTT and degassed Milli-Q was added to purified protein to make a solution up to 
0.5 mL this was incubated on ice for 30 min. A NAP-5 desalting column was equilibrated 
using 10 mL (4 column volumes) of low oxygen labelling buffer. The sample was added and 
eluted in 0.9 mL post addition into an amber tube to separate the protein from the reductant. 
The sample was diluted into 2.5 mL using labelling buffer and capped with a sealed lid. 
Using a gas-tight syringe 1 molar equivalent of AF488 was added to the sample and then 
was incubated at RT in a dark room for 30-60 min with gentle mixing (stir bar). With a gas 
tight syringe 5-10 molar excess AF594 was added and incubated for 60-120 min to saturate 
all remaining cysteines on the protein.  
To separate the protein from the free dye the samples were run over two desalting columns, 
a PD-10 desalting column and then a HiPrep 26-10 desalting column. The PD-10 column 
was equilibrated with 25 mL of labelling buffer then the solution was added and eluted with 
labelling buffer collecting 3.5 mL of eluted fluid post sample application. The HiPrep 26-10 
desalting column was equilibrated with 1 column volume ( mL) Milli-Q and then 1 column 
volume labelling buffer. Samples were added to the column and the eluted fluid was 
collected into 1 mL fractions over 1 column volume. Fractions were then screened for 
absorption at A280 and those containing protein were analysed for fluorescent activity of both 
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dyes. Those which showed fluorescent activity were pooled and concentrated in a 10 kDa 
MWCO concentrator and stored at –20°C in tubes wrapped in tinfoil or in LightSafe micro 
centrifuge tubes. 
PD-10 column was washed and stored in PD-10 wash buffer and the HiPrep 26-10 column 
was washed with 1 CV Milli-Q and stored in Milli-Q plus 20% ethanol.  
Fluorescence analysis  
The fluorescent properties of the labelled protein were analysed on the Varian Cary Eclipse 
Fluorescence Spectrophotometer and absorption data were gathered from the Cary 300.  
Labelling efficiency  
To identify the labelled protein samples fractions from the HiPrep 26-10 desalting column 
were analysed by testing the emission spectra after excitation at 488 nm or 594 nm. The 
excitation voltage varied between 600 and 900 V with an excitation slit width of either 5 nm 
or 10 nm with the aim of getting emission values between 100 and 1000 (arbitrary units). 
Samples were tested to see if they emitted light at the appropriate peaks for each dye when 
excited at the respective absorption peak wavelengths. Those which indicated the presence 
of both dyes were pooled and concentrated for future experiments.  
Once labelled samples were pooled the stoichiometry of each dye to the protein was 
determined using the absorption values given from the Cary 300. An absorption scan from 
800-200 nm was performed and the amount of each component was calculated using their 
ε. AF488 has a ε of 92,000 L.mol-1cm-1 at 495 nm, AF594 has a ε of 73,000 L.mol-1cm-1 at 
590 nm. Since both AF488 and AF594 absorb at 280 nm the following equation (1) was 
used. (A= absorbance, c= concentration) 
[𝐷𝑛𝑎𝐾] =
A280 − (𝐴495 − (𝐴590 × 0.04)) × 𝑐𝐴𝐹488 − (𝐴590 × 𝑐𝐴𝐹594)
𝜀𝐷𝑛𝑎𝐾
 
Ensemble FRET analysis 
Experiments were conducted with fluorescently labelled DnaK/Hsc70 variants to identify 
whether the conformational changes could be monitored by FRET. Labelled protein samples 
were taken and mixed thoroughly then 3×950 µL samples aliquoted out. Into each sample 
50 µL of Milli-Q, ADP or ATP (5 mM) was added and then incubated for 10 mins. 
Fluorescent emission spectra were taken in the Varian Cary Eclipse Fluorescence 
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Spectrophotometer after excitation at 490 nm, scanning from 500 to 800 nm. To normalize 
between samples a scan exciting at 590 nm measuring 600 to 800 was used. Changes 
between nucleotide states in FRET efficiency were reported using equation 2.  
𝐹𝑅𝐸𝑇 𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑖𝑒𝑠 =
𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟 𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒
𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟 + 𝐷𝑜𝑛𝑜𝑟 𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒
 
The intensity of the acceptor fluorescence (617 nm) and the donor fluorescence (519 nm) 
was averaged over 2 nm either side of the peak. Comparing FRET efficiencies of different 
nucleotide states shows how much of the energy absorbed by the donor fluorophore is 
transferred to the acceptor indicating the distance between the two dyes.  
Testing protein functionality 
Firefly refolding assay 
Firefly luciferase (0.5 mg/mL-1) was chemically denatured for at least 10 min at 25°C in 
denaturation buffer containing 1 mg/mL-1 BSA. Refolding was initiated by adding 1 µL of 
denatured luciferase to 49 µL of refolding buffer, which contained varying amounts of 
chaperones. Prior to addition of denatured luciferase 150 µL of refolding buffer was 
prepared with the desired DnaK/Hsc70 variant at differing concentrations. For functionality 
testing the rate of refolding with DnaK variants was measured at 0.5, 1 and 2 µM whilst 
Hsc70 variants were measured at 1.2, 2.4 and 4.8 µM with all tests including a negative 
control. Glycine buffer was used to make up the solution rather than Milli-Q as proteins 
were at differing concentrations. For analysis 49 µL of refolding buffer was aliquoted in 
triplicate into a white, flat-bottomed, 96 well plate prior to addition of the denatured 
luciferase. Timing started when the denatured luciferase was added and measurements were 
carried out every 2 minutes on a CLARIOstar plate reader (BMG LABTECH) Firmware 
version 1.10, using a 500-ms normalization time and a gain of 3500. Each measurement 
included a 5 s mixing step to ensure samples were adequately mixed. For routine results a 
refolding time of 10 min was sufficient for DnaK and 20 min for Hsc70. Therefore, to 
calculate the rate of refolding experiments were measured every 2 min for a duration of 30 
min.  Results were analysed by the rate of refolding relative to the no chaperone negative 
control. Results were measured over the linear portion of the graph as luciferase activity 




Results: Chapter 3 
3.1 Protein purification 
3.1.1 DnaK purification 
DnaK variants were expressed in E. coli BB1553 (∆dnak cell line) using an IPTG inducible 
promoter, with 500 mL cultures resulting in a 7-12 g pellet. Cells were grown at a lower 
temperature, 28°C, than normal E. coli cell lines due to the lack of DnaK but rate of growth 
is comparable to wild type cells. This cell line also expresses well as a prominent band at 70 
kDa is present in the cell lysate when induced overnight and run on a SDS-PAGE gel. The 
protocols for purification were designed for the purification of wild type DnaK from E. coli 
and as such have been optimised for that process. Purification followed a three-step 
chromatography protocol; anion ion exchange over a DEAE sepharose column, affinity 
purification over an ATP column and size exclusion chromatography over a S200 26-60 
column.  
Cell pellets were homogenised, sonicated and centrifuged in cell lysis buffer to prepare the 
samples for chromatography. Approximately 40 mL of cell lysate was loaded onto a DEAE-
sepharose column and DnaK containing fractions were eluted using a linear gradient elution 
of high salt buffer (Figure 5). This anion-exchange step removed any proteins that did not 
bind to the positively charged resin and removed many of the low molecular weight 
contaminants as well as nucleic acids (Figure 5, panel B). Pooled fractions (80 mL) were 
selected by the presence of a prominent band above 66 kDa (Figure 5, panel A) and dialysed 
against EDTA dialysis buffer to remove the bound nucleotide. This allows for the DnaK to 
bind to the ATP-affinity column, removing contaminant proteins which didn’t bind to the 
chromatography resin (Figure 6, panel B).  The protein was eluted through competitive 
binding with 3 mM free ATP with the fractions containing a significant amount of the 66 
kDa band being pooled for further purification (Figure 6, panel A). The chromatogram has 
a plateau following the elution of DnaK which is caused by ATP which has high 280 nm 
absorbance, due to the aromatic structure behaving similarly to that of tryptophan. Pooled 
fractions from the ATP-affinity column were concentrated down to a volume <4.0 mL for 
the final purification step via size exclusion chromatography. The size exclusion 
chromatography separates the proteins depending on size and it allows for the separation of 
DnaK into its dimeric and monomeric forms. DnaK has a propensity to form dimers as the 
SBD of one DnaK molecule can bind to the linker region of another DnaK molecule. The 




Figure 5 Purification of DnaK by anion exchange chromatography:  Panel (A) shows the 
chromatogram of DnaK (C15S/K321C/E430C) cell lysate over DEAE-sepharose and elution with salt 
gradient to 100 mM NaCl. Absorbance at 280 nm is shown in green with conductivity in mScm-1 
shown in yellow. Panel (B) Gel loading; M: Broad range molecular weight marker (500 ng per 
band) with the protein eluted into 20 mL fractions where each fraction eluted is shown in mL. 
Fractions shown in red (313-373 mL) have a prominent band above 66 kDa, corresponding to 







Figure 6 Purification of DnaK by ATP-affinity chromatography. Panel (A) shows the 
chromatogram of DnaK (C15S/K321C/E430C) dialysed DEAE pool over an ATP-agarose affinity 
column. Non-specifically bound proteins are washed off with 100 mM NaCl before ATP-bound 
proteins are eluted through competitive binding with 3 mM ATP. Absorbance at 280 nm is shown 
in green, conductivity in yellow and concentration of high salt buffer in blue. Panel (B) Gel loading; 
M: Broad range molecular weight marker (500 ng per band), elution volume for each fraction is 




Figure 7 Purification of DnaK by size exclusion chromatography. Panel (A) shows the 
chromatogram of DnaK (C15S/K321C/E430C) dialysed ATP-agarose pool over Superdex 200 26/60. 
Absorbance at 280 nm is shown in blue. Panel (B) Gel loading; M: Broad range molecular weight 
marker (500 ng per band), L: 10 µL of DEAE pool, Fractions are shown as the elution volume, with 





Figure 8 Example purity of DnaK purification. Gel loading; M: Broad range molecular weight 
marker (500 ng per band), lanes 2-9 each had 1 µL from a serial dilution of DnaK 





DnaK was identified. The second more distinct peak (~195 mL, Figure 7, panel B) is the 
monomeric form of DnaK which runs slower than the dimeric form (~165 mL, Figure 7, 
panel B). Fractions from those peaks were run on a 12% SDS gel (Figure 8, panel A) to 
identify which contained DnaK. Those fractions containing a significant amount of DnaK 
were pooled and concentrated and frozen for storage. The third and largest peak in the 
absorbance spectra (~280 mL) is due to the free ATP present in the solution from the 
previous purification step as free ATP was used in the elution buffer. The purification of 
DnaK produced >10 mg of protein at least 90% pure (Figure 9), with no major contaminants 
present and no sign of significant degradation. The relative concentration of the contaminant 
can be estimated using the dilution series, with the contaminant visible up until the 1 8⁄  
dilution and the DnaK band is visible in the 1 128⁄   dilution meaning that the contaminant 
contributes to < 1 16⁄   of the total protein.  
3.1.2 Hsc70 purification  
Hsc70 variants were expressed in E. coli BB1553 DE3 (MC4100 ΔdnaK52::Cmr sidB1) 
using an T7 IPTG inducible promoter, with 500 mL cultures resulting in an approximately 
4 g pellet. This cell line was cultured at a lower temperature and has a greatly diminished 
rate of cell division with a doubling time of approximately 2 hours, compared to the 20 
minutes for wild type E. coli. When run on a SDS-PAGE gel the cell lysate indicated the 
expression of a ~70 kDa band after overnight induction with IPTG. When compared to the 
DnaK expression the expression of Hsc70 and its variants is significantly lower and grows 
at a slower rate. After growth and expression, the Hsc70 purification followed the DnaK 
three-step chromatography protocol, with one modification during the DEAE column.  
Cell pellets were homogenised, sonicated and centrifuged in cell lysis buffer to prepare the 
samples for chromatography, approximately 40 mL of cell lysate was loaded onto the 
DEAE-sepharose column. In the first purification of a Hsc70 variant the protocol used was 
the same as the one used for DnaK, with the protein being eluted over a linear gradient of 
high salt buffer (Figure 10, panel A). When eluting over a linear gradient the Hsc70 peak 
overlaps with another protein peak (L-tryptophanase, identified via mass spectrometry), is 
retained over the two following purification columns. The Hsc70 band can be seen in the 
highlighted fractions in Figure 10, panel A (17–19, red) as the band just above 66 kDa and 
the contaminant protein is seen by the prominent band at 45 kDa seen in fractions 15-17 





Figure 9 Purification of Hsc70 using original DnaK purification protocol. Panel A: 12% SDS PAGE of 
fractions eluted off DEAE ion exchange column, Gel loading; MWM: Broad range molecular weight 
marker (500 ng per band), Fractions 13-22: 10 µL of 2.5 mL fractions. Fractions 17-19 (labelled red) 
with a single band above the 66 kDa marker were pooled for further purification. Panel B: Fractions 
eluted off of ATP-affinity column, Gel loading; MWM: Broad range molecular weight marker (500 
ng per band), CL: clarified lysate, fractions are labelled with eluted volumes, with those in red 
pooled for further purification. Panel C: Fractions eluted off of S200 size exclusion column, Gel 
loading: MWM: Broad range molecular weight marker (500 ng per band), fractions labelled with 
eluted volumes.  
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To separate Hsc70 from L-tryptophanase a linear step was introduced into the elution 
gradient on the DEAE column (Figure 10, panel A), as the contaminant appeared to elute at 
a slightly higher salt concentration conductivity than the Hsc70. The new protocol for 
purifying Hsc70 includes a linear gradient to 17 mS.cm-1 followed by an isocratic step then 
a linear gradient up to 100% high salt buffer. By introducing a step in between Hsc70 and 
L-tryptophanase at 17 mS.cm-1 the best separation between the two proteins was seen whilst 
retaining most of the Hsc70 protein (Figure 10, panel B). The linear step in the anion 
exchange chromatography increases the separation of Hsc70 from proteins which don’t bind 
to the resin as well as separating out the Hsc70 from other contaminants and low molecular 
weight proteins. Pooled fractions (Figure 10, panel B, 360-420 mL, red) were selected by 
the presence of a prominent band just above the 66 kDa marker and the absence of any other 
significant contaminants. 
 The pooled fractions (60 mL) from each purification were dialysed in EDTA buffer to 
remove the bound nucleotide, allowing for binding to the ATP column. After loading the 
pooled proteins onto the column, a high salt wash was preformed to remove any protein that 
had ionically bound to the column or the Hsc70 (Figure 11, panel A). The protein was eluted 
through competitive binding with 3 mM free ATP with the protein peak visible as a shoulder 
on the ATP peak (Figure 11, panel A). When comparing the two different purifications of 
Hsc70 on a SDS-PAGE gel of the eluted fractions it becomes strikingly obvious the 
difference in purity. The purification with the linear elution over the DEAE column has two 
distinct bands present after ATP-affinity chromatography, one just above 66 kDa and one at 
45 kDa (Figure 9, panel B). The elution of the protein also had a long tail, with significant 
amounts of protein still being eluted >10 mL after the addition of the free ATP. In the 
purification with a 17 mS.cm-1 step, most of the protein elutes in the first 10 mL after the 
addition of free ATP and the protein is eluted in a single peak without a significant tail 
(Figure 11, panel B). Although there is still a small amount of contaminant present in the 
Hsc70 containing fractions the relative amount is significantly decreased compared to the 
amount present in the previous preparation technique. This suggests that the Hsc70 is 
binding to the L-tryptophanase allowing them to co-elute over both the ATP-agarose and 
S200 size exclusion columns. There was no literature found indicating a significant 








Figure 10 Purification of Hsc70 by DEAE chromatography. Panel A: shows the chromatogram of 
Hsc70 (E255C/T427C/C574S/C603S) cell lysate over DEAE-sepharose and elution with up to 100 
mM NaCl. Absorbance at 280 nm is shown in green, conductivity in yellow and concentration of 
high salt buffer in blue. Panel B: 12% SDS PAGE, Gel loading; M: Broad range molecular weight 
marker (500 ng per band), L: 10 µL of clarified lysate, Fractions are shown as eluted volumes: 10 µL 
of each 20-mL fraction. Fractions shown in red with the large band above 66 kDa, were pooled for 













Figure 11 Purification of Hsc70 by ATP-affinity chromatography. Panel A: shows the 
chromatogram of Hsc70 (E255C/T427C/C574S/C603S) DEAE-pool over ATP-affinity column. Non-
specifically bound proteins are washed off with 100 mM NaCl before ATP-bound proteins are eluted 
through competitive binding with 3 mM ATP. Absorbance at 280 nm is shown in green, conductivity 
in yellow and concentration of high salt buffer in blue. Panel B: 12% SDS PAGE, Gel loading; M: 
Broad range molecular weight marker (500 ng per band), Fractions shown as eluted volumes, with 
every second fraction run on the gel: 10 µL from 1 mL for each fraction. All fractions between 67-








Figure 12 Purification of Hsc70 by size exclusion chromatography. Panel (A) shows the 
chromatogram of Hsc70 (E255C/T427C/C574S/C603S) dialysed ATP-agarose pool over Superdex 
200 26/60. Absorbance at 280 nm is shown in green. Panel (B) Gel loading; M: Broad range 
molecular weight marker (500 ng per band), Fractions shown as elution volumes: 10 µL of each 2.5 











Figure 13 Example yield and purity of Hsc70 purification. Gel loading; M: Broad range molecular 
weight marker (500 ng per band), lanes 2-8 each had 1 µL from a serial dilution of the concentrated 














After ATP-affinity purification, the fractions with a significant amount of Hsc70 were 
pooled and concentrated through a 10 kDa molecular weight cut-off filter until total volume 
was <4.0 mL. The Superdex S200 26/600 chromatography column separates out the proteins 
depending on size, removing remaining protein contaminants and allowing for separation of 
Hsc70 into its different aggregation states. As with the DnaK preparation the last major peak 
(~300 mL) is made up of the ATP still present from the ATP-affinity column, with the Hsc70 
being eluted in the other significant peak (~200 mL) (Figure 12, panel A). The Hsc70 peak 
is similar to composition as those from the DnaK purification with the protein being 
separated into its monomeric, dimeric and other aggregate states. The fractions from the 
protein peak were run on a 12% SDS gel and the results of the two different purifications 
are shown in Figure 9C and 12B. The fractions from the original preparation technique have 
two distinct bands at 66 and 45 kDa, the contaminating protein being retained over the 
column. In the modified Hsc70 purification technique there is only one major protein band 
present, with little to no sign of the L-tryptophanase present; the faint contaminant bands are 
more likely to be the SBD and NBD domains of the Hsc70. Once purified the concentrated 
Hsc70 was diluted in series to calculate the concentration and purity of the protein, with the 
dilution series being run on a 12% SDS-PAGE gel (Figure 13). Using densitometry and the 
comparison software ImageJ the concentration of total protein for the purification shown 
was estimated to be 4 mg.mL-1 (±10%), of which the largest single contaminant contributing 
to less than 5% of the total protein. The protein bands from the purified samples were 
analysed by mass spectrometry to identify the protein present and to ensure that the correct 
Hsc70 variant had been purified. For most purifications the total yield of protein was not as 
high as the purification shown, with approximately 1 mg.mL-1 purified for most proteins 
variants, however the purity of each of these purifications remained the same with no 
significant contaminants present for any of the variants. This analysis was done using a 




3.2 Fӧrster resonance energy transfer (FRET) 
3.2.1 Fluorescent labelling 
Fӧrster resonance energy transfer is a technique used to monitor the proximity of two 
fluorescently labelled molecules. To monitor the movement between the substrate binding 
domain and nucleotide binding domain Alexfluor488 and 594 dyes were attached to 
introduced cysteine residues on each domain. To attach the Alexafluor™ dyes to the cysteine 
residues the protein was reduced using a reductant, originally with tris(2-carboxyethyl) 
phosphine (TCEP), then this was changed to DTT (dithiothreitol) for improved labelling 
efficiencies. The protein is reduced then run through a NAP5 desalting column to separate 
the reduced protein from the reductant prior to addition of the dyes. This step is important 
for the labelling protocol as it removes the reductant which would compete with the protein 
in subsequent steps. In the following steps the reduced cysteine residues on the protein react 
with the Alexa Fluor dye to form a thioester bond which is then analysed in the FRET 
experiments. If the reductant is still present during the labelling reaction it will compete with 
the cysteines to form a dye-reductant conjugate. Because the reductant is added in excess 
prior to the NAP-5 column to ensure that the protein is fully reduced, separation of the 
reductant is essential for optimal labelling conditions. The labelling protocol uses 
stoichiometric amounts of the donor Alexa Fluor so any remaining reductant would interfere 
with this reaction. After the labelling is complete the free dye is removed by purifying over 
two desalting columns, a PD-10 and a HiPrep 26/10 desalting column (Figure 14). After 
labelling with TCEP there is a significant amount of free dye still present after the first 
desalting column (PD-10), which is removed over the HiPrep 26/10 desalting column 
(Figure 14, panel A). The first peak (~150 seconds) is the protein peak and there is little 
overlap with the secondary peak (400 seconds) which is the free dye. Although the overlap 
between the peaks is small it makes the following experiments difficult to reliably interpret 
as most are made on the assumption that no free dyes are present. When the labelling is 
performed using the reductant DTT the majority of the free dye is removed during the first 
desalting column. The remaining free dye is removed during the HiPrep 26/10 desalting 
column and can be seen eluting off the column at ~50 mL as seen by the increase in 
conductivity (Figure 14, panel B). Since there is so little remaining free dye present in the 





Figure 14 Separation of unincorporated label via desalting chromatography. Panel (A) shows the 
chromatogram of Hsc70 (E255C/T427C/C574S/C603S) following the fluorescent labelling protocol 
using TCEP as the reductant. Panel (B) shows the chromatogram of Hsc70 
(E255C/T427C/C574S/C603S) following the fluorescent labelling protocol using the reductant DTT. 











Figure 15 Identification of fluorescently labelled chaperone protein (Hsc70 
E255C/T427C/C574S/ C603S). Panel (A) shows the emission spectra after excitation at 490 nm for 
the fractions collected after desalting chromatography (Figure 14, panel A). Each fraction was 
excited separately using the same parameters and measured using the Cary Eclipse fluorescence 
spectrophotometer (Varian). Panel (B) shows the emission spectra after excitation at 590 nm. 
Each fraction was excited separately using the same parameters and measured using the Cary 
Eclipse fluorescence spectrophotometer (Varian) The maximum emission measurable is 1000 
units so the dye peak was also analysed at a lower voltage to ensure that the emission spectra 




In the TCEP labelled samples, it was not clear that all the free dye had been removed from 
the protein containing fractions. Each fraction from the protein peak was tested for the 
presence of each fluorophore before pooling to see if there was any free dye present in the 
fraction. To test for the presence of each Alexafluor the fractions were excited at both 488 
and 594 nm and the emission spectra were measured (Figure 15). This test was used to 
identify fractions which contained proteins and the two Alexa Fluor dyes after the free dye 
had been separated out using desalting chromatography. The fractions that showed emission 
spectra matching each of the Alexa Fluor dyes were all pooled together for FRET analysis.  
When testing the fractions for Alexafluor 488 the protein containing fractions were 
compared as well as testing the dye peak (Figure 15, panel A). Fractions 10-16 showed a 
significant amount of emission at the AF488 emission peak when compared to the blank. 
These data also supported the fact that free dye had been removed from the protein; if there 
was free dye present in the solution from the dye peak then the later fractions would have 
increased amounts of dye. The highest amount fluorescence was seen in fraction 14 which 
corresponds to the protein peak. When analysing the dye peak there was a secondary peak 
on the emission spectra corresponding to the emission peak of AF594, which absorbs 
slightly at 488 nm. Because AF594 is added in excess in the labelling protocol the small 
amount of absorbance is amplified, which is why it is not apparent in the protein fractions. 
The fractions were tested for AF594 by excitation at 594 nm and measuring the emission 
spectra. Protein containing fractions 10-16 all showed a significant amount of emission at 
the AF594 emission peak, with the later fractions showing increased levels of emission when 
compared to the AF488 emission profiles. In fraction 16 the amount of emission after 
excitation at 488 nm is equivalent to fraction 12, yet after excitation at 594 nm there is a 
substantial increase in the emission spectrum of fraction 16 relative to fraction 12. This may 
be due to free dye begin to elute off of the column starting to contaminate the sample. The 
samples from DTT labelling experiments were not tested as thoroughly as there was little to 
no free dye present after the first desalting column, so only the fractions at each end of the 
protein peak were excited to identify which fractions to pool.  
3.2.2 Labelling efficiency  
The basis of the FRET experiment is to track the movement between nucleotide binding 
domain and the substrate binding domain in response to the bound nucleotide. The attached 
fluorophores on each domain will undergo FRET from the donor chromophore (AF488) to 
the acceptor chromophore (AF594). For this interaction to occur both introduced cysteine 
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residues on the variant protein must have attached fluorophores and one must be a donor 
and the other an acceptor. The site that each fluorophore binds to is not important as long as 
both the donor and acceptor are attached to the same protein. The labelling protocol adds 
the donor fluorophore (AF488) at equimolar concentration so that ideally 50% of the 
reduced sites will have the donor fluorophore attached. The sample is then saturated with 
excess acceptor fluorophore (AF594) so that all remaining reduced cysteines are occupied. 
To quantify the number of protein molecules with attached fluorophores stoichiometric 
measurements were calculated of the pooled desalting fractions via an absorption spectra as 
each molecule has a distinct absorbance peak (Figure 16).  The two chromatograms show 
the absorption spectra after labelling using either TCEP or DTT as the reductant, with three 
key absorbance peaks at 590, 490 and 280 nm. Both chromatograms have been calibrated 
against a buffer blank, with the values at each peak being used to calculate the stoichiometry 
of each solution. AF 594 has a ɛ value of 73,000 L.mol-1.cm-1 at 590 nm, AF488 has a ɛ 
value of 92,000 L.mol-1.cm-1 at 495 nm and Hsc70 and DnaK have ɛ values of 33,600 and 
24,200 L.mol-1.cm-1 at 280 nm respectively. To accurately determine the concentration of 
each molecule in the solution the concentration of AF594 was calculated first as it also 
absorbs at the peaks for AF488 and protein, and then the concentration of AF488 is 
calculated as it also absorbs at 280 nm.  
 Once the stoichiometry of the solution has been calculated the labelling ratios can be 
calculated with the amount of protein with one residue labelled, two residues labelled with 
the same Alexafluor or both residues labelled with an acceptor donor pair (Table 1). The 
calculated values assume that there is no free dye present in the solution and emphasizes the 
significance of changing the reductant from TCEP to DTT. The first major difference 
between the two protocols is the total proportion of labelled sites, with approximately 15% 
of cysteines labelled when TCEP was used and up to 98% when DTT was used. For 
ensemble FRET experiments the key ratio is the amount of protein that has both the donor 
and the acceptor fluorophore, compared to the total amount of donor fluorophore. In the 
TCEP labelling experiment ~8.6% of all the donor Alexafluor488 is paired with the acceptor 
Alexafluor594 whilst in the DTT labelling experiment 59% of AF488 is paired with AF594. 
It should be noted that the total % of protein labelled correctly is still relatively low with 
approximately 18% of all the protein labelled with both dyes. It should be noted that the 
majority of the protein labelled will be bound with two acceptor dyes, this is used to 






Figure 16 Stoichiometry of labelled chaperone protein. Panel (A) shows the absorbance spectra 
of labelled Hsc70 (E255C/T427C/C574S/C603S) after labelling protocol using TCEP. Panel (B) 
shows the absorption spectra of labelled DnaK (C16S/K321C/E430C) after labelling protocol using 
DTT. Samples were measured using the Cary 50 Bio UV-visible spectrophotometer (Varian) after 















Table 1: Labelling ratios of each AlexaFluor™ dye  
 
Values  presented  are  relative  amounts  of  Hsc70  (E255C/T427C/C603S)  or  DnaK  
(C16S/K321C/E430C) with the corresponding dye attached. All values presented assume that 
there are no free dyes present in the solution. *Relative to the amount of protein labelled with 
AlexaFluor488  
 Example calculation: 
When TCEP is used as the reductant, how much of the protein has AlexaFluor488 attached at one 
site and has the other site free? 
First calculate the concentration of the protein, AF488 and AF594 
c =  A/ɛl Where the ɛ of the protein is 0.0036 for the protein at 280 nM, 0.092 for 
AF488 at 495 nM and 0.073 for AF594 at 590 nM and the pathlength is equal to 1 
Protein = A280/0.0036;  0.0228/0.0036 = 0.680 
 AF488 = A495/0.092;  0.006965/0.092 = 0.0757 
AF594 = A590/0.073; 0.1243/0.073 = 0.1243 
Then because there are two sites per protein molecule work out the relative concentration of the 
Alexafluor dyes to the available sites 
Relative amount of AF488 = cAF488/(cProteinx2); 0.757/(0.680x2) = 0.0557 per site 
Relative amount of AF594 = cAF594/(cProteinx2); 0.1243/(0.680X2) = 0.0914 per site 
Then calculate the number of free sites (assuming no free dye)  
  Free sites = Total sites – bound sites; 1-0.0557-0.0914 = 0.8528 
Then calculate the amount of proteins which has AF488 at one site and has the other site free 
(Single 488) (assumes random binding of proteins) 





3.2.3 Ensemble FRET 
Ensemble FRET was used to detect the movement between domains of fluorescently 
labelled DnaK and Hsc70 variants. A change in conformation of the chaperone protein will 
alter the inter-fluorophore distance and can be tracked with the emission spectrum after 
excitation at 490 nm. An increase in energy transfer indicates a decrease in inter-fluorophore 
distance relating to the compaction of the domains characteristic of Hsp70 family proteins. 
All chaperone variants were measured in three nucleotide binding states, with no nucleotide 
bound to the ATP domain or in the presence of excess ADP or ATP. For both Hsc70 and 
DnaK four variants were analysed with a single variant for both Hsc70 and DnaK showing 
a FRET response to nucleotide state, Hsc70 (E318C/T427C/C574S/C603S) and DnaK 
(C16S/K321C/E430C). Ensemble FRET results for both a non-active and both of the active 
FRET variants show clear differences in nucleotide state responses (Figure 17).  
The Hsc70 variant 2T (E255C/T427C/C574S/C603S) shown in Figure 17 panels A and B 
demonstrates the typical response of a variant which does not exhibit a FRET change in 
response to nucleotide state. There are a number of reasons which may cause the lack of 
FRET change, this could be due to either the mutations causing the variant to lose its ability 
to alternate between its nucleotide bound states or that introduced cysteines were not placed 
informatively for FRET studies. All four plots in Figure 17 were normalised against the 
emission spectra after excitation at 590 nm to account for any discrepancies between 
samples and stoichiometric analysis indicated that for this sample ~47% of AF488 present 
was paired to a AF594 acceptor. The emission spectra show a quenching of the 519 nm peak 
after the addition of ADP and ATP but no corresponding increase in the 617 nm peak. The 
519 nm peak shows a 10% decrease in fluorescence in the ADP bound state and a 15% 
decrease in the ATP bound state (Figure 17, panel A) this indicates that there are three 
different states that the protein is occupying. Due to the sensitivity of the machine and the 
low levels of fluorescence a 10% change in emission at the 617 nm may not have been 
visible so the same sample was analysed using a wider excitation slit width, resulting in 
increased absorbance and consequent emission (Figure 17, panel B). The results show that 
there is no discernible change in emission at 617 nm, indicating no energy transfer between 
the fluorophores. The basal fluorescence from the acceptor is probably due to a combination 
of low levels of energy transfer from the donor fluorophore and the direct excitation of the 







Figure 17 FRET in response to nucleotide state for labelled chaperone proteins. Panel (A) shows 
the emission spectra of labelled Hsc70 (E255C/T427C/C603S) after excitation at 490 nm. Panel (B) 
shows the emission spectra of labelled Hsc70 (E255C/T427C/C603S) after excitation at 490 nm 
with a wider excitation width (10 nm compared to 5 nm). Panel (C) shows the emission spectra of 
labelled DnaK (C16S/K321C/E430C) after excitation at 490 nm. Panel (D) shows the emission 
spectra of labelled Hsc70 (E318C/T427C/C574S/C603S) after excitation at 490 nm. All four plots 
were normalised to emission from 594 nm excitation, with nucleotide free plotted in blue, ADP 





The variants DnaK KE (C16S/K321C/E430C) and Hsc70 3T 
(E321C/T427C/C574S/C603S) are shown in panels C and D both showing the change in 
emission spectrum after altering the nucleotide state of the protein. Both plots were 
normalised against the emission spectra after excitation at 590 nm and the stoichiometric 
analysis indicated that >50% of the AF488 donor was paired to a AF594 acceptor. The 
variants exhibit a FRET change in response to the nucleotide state of the protein, with 
changes in the donor peak corresponding to changes in the acceptor peak. The emission 
spectra show a quenching effect at the 519 nm peak in response to the addition of either 
ADP or ATP with a decrease in fluorescence of 5% when ADP is bound and of 20% when 
ATP is bound. The peak corresponding to the acceptor fluorophore showed a change in 
emission when nucleotide is bound, with an increase in emission of 15% when ADP is bound 




 where the intensity of the acceptor fluorescence 
(617 nm) and donor fluorescence (519 nm) was averaged over 2 nm either side of the peak. 
The FRET efficiency is the amount of the energy transferred between the donor and the 
acceptor and depends on the distance between the donor and the acceptor. In the DnaK KE 
variant the no nucleotide state has a FRET efficiency equal to 0.10 compared to 0.13 for 
ADP bound and 0.17 for ATP bound state. In the Hsc70 variant 3T the FRET efficiency is 
equal to 0.10 in the nucleotide bound state, 0.12 in ADP bound state and 0.22 in the ATP 
bound state. This increase of efficiency relates to a decrease in distance between the two 
fluorophores in the protein indicating there was a conformational change. Due to the nature 
of the ensemble experiment it is difficult to calculate the change in distance between the 
different nucleotide states. Because the labelling experiment gives a heterogeneous sample, 
getting an accurate calculation of the change in distance would be difficult as it can’t be 









3.3 Chapter summary 
The results from this chapter showed that modifying the purification protocol of Hsc70 
variants leads to better separation of the protein from a major contaminant, L-tryptophanase, 
which was retained over all three columns. The purified protein product was labelled with 
AlexaFluor dyes AF488 and AF594 using both TCEP and DTT, with the DTT reductant 
leading to substantial increase in the labelling efficiency of the reaction and cleaner 
separation of the labelled protein from the free dye. The FRET efficiency in response to 
nucleotide state was assessed and a single variant for both DnaK and Hsc70 showed a change 
upon nucleotide binding.  
In order to test why most of the variants may have shown no change in FRET efficiency and 
to confirm that the variants DnaK KE and Hsc70 3T are good models for the wildtype protein 
each variant was tested for protein refolding activity. The next chapter shows the results of 





Results: Chapter 4 
4.1 Luciferase assay 
To test the activity for each of the chaperone variants, the ability of each variant to increase 
the rate of refolding of denatured luciferase was examined. The recombinant luciferase has 
been used in prior studies (Gestwicki et al., 2008) to show rates of refolding as it emits light 
when in the folded state allowing for easy quantification. The rate of luciferase activity 
recovery in the presence of each mutant was compared to the intrinsic rate of unassisted 
refolding and to the wildtype chaperone to test the effect that the introduction of cysteine 
residues had on the protein refolding function of the chaperone. The luciferase assay was 
modified from the published protocol, with the refolding reaction and luminescence 
measurement occurring at the same time. This new method utilized the fact that emitted light 
is not a persistent product so there will be no build up over time allowing for the same sample 
to be measured over time, giving a more accurate and simplified method. Due to a significant 
change in the previous protocol the reliability and sensitivity of the test was examined using 
wild type DnaK. Previous protocols had been calibrated and tested using wild type DnaK so 
using this chaperone allowed for a direct comparison to the protocols from previous studies 
(Wisen and Gestwicki, 2008, Groemping et al., 2001). The results from the luciferase 
refolding assay show a dependence on the presence of both DnaK and the cochaperones as 
expected from previous studies.  
The rate of refolding was tested in response to changing DnaK concentration with the change 
in luminescence being measured over time (Figure 18). DnaK is the rate limiting step in 
chaperone assisted refolding so by testing against DnaK concentration the sensitivity of the 
reaction can be determined and variant proteins can be calculated as a proportion of wild 
type. This experiment tests rate of refolding for each of the protein concentrations as well as 
the overall change in the total refolding activity, with each assay approaching a plateau. The 
plots of the different concentrations all follow a similar curve with an initial lag phase for 2 
minutes followed by linear rate of luminescence increase until 10–20 minutes after which it 
begins to plateau (Figure 18, panel A). The blank containing no DnaK shows a slight 
increase in luminescence which reflects the intrinsic refolding activity of the protein and 
reflects the percentage of the protein which will refold without chaperone assistance. The 
three chaperone containing plots show an increase in both the rate and overall increase in 





Figure 18 Luciferase refolding assay in response to DnaK concentration. Panel (A) shows the 
change in luminescence over time in response to DnaK concentration. All samples were measured 
in triplicate and averaged with the error bars showing the maximum and minimum values. The 
concentration of DnaK is shown in the legend with 0.75 µM in grey, 1.5 µM in orange, 3.0 µM in 
blue with the blank shown in yellow. Panel (B) shows the relation between DnaK concentration 
(mM) and the amount of luminescence, the strength of the relationship is shown as the R-squared 
value. The luminescence value is taken from the linear part of the curve before the rate of refolding 








Figure 19 Experimental controls for modified luciferase assay. Panel (A) shows the luminescence 
of the refolding assay in the presence of different chaperone and cochaperone proteins, 
cochaperone concentration was at the same concentration as in functionality testing and DnaK was 
measured at 1 µM. The dark blue plot shows the change in luminescence with DnaK and both 
cochaperones GrpE and DnaJ. The Orange plot shows the same reaction without the cochaperone 
GrpE, and the green (lacking DnaJ), yellow (lacking DnaJ and GrpE) and light blue (lacking DnaK) all 
overlapping. Panel (B) shows the luminescence of the refolding assay in relation to DnaJ alone. The 
orange plot shows the refolding with DnaJ and the blue plot shows the no DnaJ blank. The error 
bars show the minimum and maximum values from testing. Panel (C) shows the refolding assay 
after a denaturation time of 2 minutes. DnaK concentrations are 3, 1.5 and 0 µM for the blue, 
orange and grey plots respectively. The error bars show the range of results from technical repeats 
from the same experiment. Panel (D) shows the refolding assay without the presence of 





first 10 minutes then begins to plateau with very little change seen after 20 minutes. The 
change in the rate of refolding is calculated from the linear part of the curve and is used to 
compare different concentrations or variants. In this experiment, a linear relationship 
between DnaK concentration and the amount of luminescence is seen with the higher 
concentrations of DnaK showing higher amounts of refolding activity. This relationship is 
highlighted in panel B, with the concentration plotted against the change in luminescence 
activity during the linear part of the graph, which was taken from 4 to 14 minutes for all 
plots. This graph shows a strong linear relationship between the concentration of DnaK and 
the amount of luminescence, with a correlation coefficient of 0.98 when the averages of each 
time point was used. These data indicate that the new protocol was sensitive to a change in 
overall chaperone activity as well as providing a reliable indication on the amount of 
activity.  
After showing that the new method could detect the changes in the overall chaperone activity 
other controls were tested to ensure that the change in activity was due to the change in the 
chaperone concentration and that the method was sensitive to the same parameters as the 
previous test: cochaperone dependence, change in denaturation time, sensitivity of refolding 
assay without cochaperones.  The effect of cochaperones, DnaJ and GrpE, on their ability to 
help facilitate protein refolding was tested (Figure 19, panel A). The luciferase refolding 
assay shows the effect of cochaperones on the activity of DnaK, showing a dramatic 
decrease in activity when either DnaJ or GrpE is removed. The dark blue plot shows the 
assay with all the protein components and displays the normal refolding response, which has 
a change in luminescence units of 210,000 per minute. The orange plot shows the same 
reaction without the cochaperone GrpE, which shows that GrpE is important but not 
essential to the proper function of DnaK. There is a significant increase in luminescence 
when compared to the no DnaK control (light blue) with the change in luminescent units per 
minute increasing to 55,000 per minute from the change of 6,600 per minute of the blank, 
however it has approximately a quarter of the activity of the fully functioning protein. The 
no DnaJ and no cochaperone (no DnaJ and GrpE) assays show very slight increase in activity 
over the blank which is not discernible on this scale so the no cochaperone assay was 
repeated in panel D at different protein concentrations. The sensitivity of the assay to DnaK 
concentration without cochaperones present was tested and shows that the assay can detect 
DnaK activity at 1.5 µM (orange plot) after 20 minutes and the 3.0 µM concentration (blue 
plot) can be detected at 10 minutes. 
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One of the most important experiments is to ensure that the blank, the 0 µM DnaK, gives an 
accurate representation of the true negative: that no refolding activity was due to the other 
protein chaperone DnaJ. To test DnaJ refolding activity two assays were run in the absence 
of DnaK (Figure 19, panel B), one with DnaJ (plotted in orange) and one without (plotted 
in blue). The graph shows that there is no difference between the negative control and the 
sample with DnaJ present, with the range of values for each overlapping considerably. This 
indicates that DnaJ alone neither accelerates nor retards the intrinsic rate of refolding with 
the negative control and the 0 µM DnaK control showing no significant difference. Finally, 
the denaturation time of luciferase was tested as it is important for the speed and the 
efficiency of the assay so the amount of time it takes to denature before refolding results can 
be separated was tested. For practical reasons the shortest denaturation time that was tested 
was a period of 2 minutes from addition of the luciferase to the denaturation buffer to the 
addition to the refolding buffer. The results from that experiment show that the 2-minute 
period provided sufficient denaturation of protein as there was very little activity in the blank 
at time zero, suggesting that the majority of the luciferase had been denatured and a clear 
refolding response to increased DnaK could be observed. When conducting chaperone 
activity assays the proteins were used at a concentration of 0.5-4 µM in a 50 mM glycine 
buffer (pH 7.8) with DnaJ at a concentration of 48 nM, GrpE at 24 nM and luciferase at 





4.2 DnaK variant functionality  
The activity of the DnaK chaperones were assessed at three different concentrations to 
examine both the variants activity relative to wild type and response to stoichiometric 
changes. Each variant was also measured in relation to a control refolding reaction with no 
chaperone present to measure the additional refolding activity relative to the inherent rate of 
spontaneous refolding. All of the variants were measured over a 30-minute period at 
concentrations of 0.5, 1 and 2 µM, with each variant measured and plotted separately. The 
different concentrations are plotted as diamonds, circles and triangles for the 0.5, 1 and 2 
µM respectively with each variant plotted as distinct colours (Figures 20 and 21). At 2 µM 
all four of the variants show a substantial increase in activity over the inherent rate of 
refolding, however at 0.5 and 1 µM the variants differ in their response. Three of the mutants, 
KE, NE and NR, show very little additional refolding activity at both 0.5 and 1 µM however 
the fourth mutant KR shows increased activity at both 0.5 and 1 µM.  
The variant KR (C15S/K321/R520C) shown in yellow (Figure 20, panel B) shows an 
increase in activity at 0.5 and 1 µM, with both showing significant increases in activity, 
~190% and ~400% rate of refolding respectively, when compared to the blank during the 
linear phase. At 2 µM there is no further increase in refolding rate when compared to the 1 
µM concentration, however the reaction is not run long enough to observe the plateau so a 
change in overall yield may still occur. Prior to the linear phase there is a minor lag phase 
in which all three concentrations of KR have reduced refolding function when compared to 
the blank, however this is hard to see on the graph due to the scale. The variant KE 
(C16S/K321C/E430C) shown in red, shows a positive relationship between concentration 
and the increase in luminescence. At 0.5 µM there is very little additional activity and it is 
indistinguishable from the 0 µM concentration in the linear phase with differences only 
becoming apparent as the refolding assays approach the plateau. The 1 µM concentration of 
KE provides a ~20% increase in activity from the blank, however at 2 µM concentration 
there is a substantial increase in activity. At 2 µM the activity increases to ~360% that of the 
intrinsic rate of refolding indicating the increase in activity is not proportional to the increase 
in concentration. The third variant NE (C15S/N251C/E430C) and fourth variant NR 
(C15S/N251C/R520C) shown in green and brown both shows the same pattern of activity 
in relation to concentration as KE. However, there are some difference in the refolding 
response between the three variants. In KE and NR there is a constant increase in the rate of 
refolding with the 1 and 2 µM concentrations providing an increase in activity from addition 
54 
 
through to the plateau. In the NE variant, there is a lag phase in which the protein containing 
fractions show no additional activity relative to the blank, but unlike the KR variant there is 
no decrease in protein refolding activity.  
To compare the relative activity for each of the DnaK variants rate of refolding by all 
variants were analysed in a single experiment. GrpE was omitted from this assay so that 
Hsc70 and DnaK variants could be compared as GrpE has no effect on the activity of Hsc70. 
The four DnaK variants were analysed along with wild type DnaK at 1 µM concentration 
(Figure 21) as well as 0.5 and 2.0 µM. The results from the experiment reinforces that each 
variant has a positive effect on the refolding of denatured luciferase as each variant has 
increased luminescence when compared to the blank. Three of the variants, KE, KR and NR 
had a significant decrease in function when compared to wild-type DnaK at 1 µM 
concentration, with the luminescence from KE and NR refolding assays exhibiting ~33% of 
the rate of refolding for luciferase from wild type refolding assays over the time period from 
6-15 minutes. Over the same time period the mutant KR exhibited ~50% of the refolding 
activity of the wild type refolding whilst the mutant NE showed no notable change in 
refolding activity when compared to wildtype DnaK. It should be noted that these rates are 
relative to the wild type and do not account for the intrinsic rate of refolding shown in the 
blank. To calculate the additional refolding activity each of the variant proteins have over 
the intrinsic refolding, the blank was subtracted from the wild type results and each of the 
variants. This caused the activities relative to wild type to fall to ~20% for KE and NR and 
~40% for KR whilst NE showed no change in activity relative to wild type function. The 
fact that these curves differ from those in the individual could be explained by the absence 
of GrpE from the reaction in Figure 21. Both KR and NE show different refolding responses 
to those seen in Figure 20 which may be related to the lag phase observed in each protein, 






Figure 20 Luciferase refolding assays using DnaK variants. The change in luminescence over time 
was recorded for refolding assays using DnaK variants KE (red, panel A), KR (yellow, panel B), NE 
(green, panel C) and NR (brown, panel D). On each graph the 0 µM control was shown in blue and 
the three concentrations used in each experiment are 0.5, 1 and 2 µM shown as a diamond, circle 
and triangle respectively. For panels A, C and D the 0.5 µM concentration and the blank values 
overlap so the blank is not visible on the graph.  
 
Figure 21 Comparison of DnaK variants to wild type.  Shows luminescence vs time for the four 
DnaK variants along with wild type (WT) all at 1 µM concentration and the no DnaK negative control 
(Blank), all these variants were run without the cochaperone GrpE. The 6 plots follow the same 
colour scheme as in Figure 15; WT = dark blue, NR = Brown, KE = Red, KR = Yellow, NE = Green, 
Blank = Blue. Error bars show the range of results gathered, plotting the maximum and minimum 
data points gathered from the technical replicates, with most falling within the dots.  
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4.3 Hsc70 variant functionality 
Hsc70 variants were analysed using the luciferase refolding assay, with the four variants 
used in the FRET experiments as well as Hsc70 2C (C574S/C603S). Hsc70 2C is the variant 
with both native cysteines in the Hsc70 are mutated to serine residues so that they cannot be 
bound by the Alexafluor dyes. Each variant was measured at 1.2, 2.4 and 4.8 µM 
concentration over a 30-minute period to view the change in refolding activity in response 
to concentration. The Hsc70 variant 2C (C574S/C603S) was tested to see if there was any 
effect on mutating the C-terminal domain cysteine residues and this is shown in Figure 22 
(panel A).  An increase in luminescence is observed in refolding assays containing 2C, with 
all three concentrations showing increased activity relative to the blank, however there is no 
significant difference in luminescence after 2.4 µM. The 1.2 and 2.4 µM concentrations of 
2C both show increases in activity with the 2.4 µM having approximately double the 
additional activity of the 1.2 µM concentration. The increase the rate of refolding is ~35% 
in the 1.2 µM during the first 16 minutes of the reaction and ~80% at 2.4 µM concentration. 
There is no significant increase in luminescence after 2.4 µM concentrations indicating no 
increase in the rate of refolding. The luminescence of neither 2.4 or 4.8 µM Hsc70 2C had 
reached a plateau, so over a longer period a difference in total refolding activity may have 
been observed between the two concentrations.   
Two of the Hsc70 variants 2T and 3T showed similar changes in rate of refolding in response 
to changes in protein concentration. 2T (panel E) and 3T (panel C) both show a positive 
almost linear relationship between rate of refolding and the concentration of chaperone 
protein. 2T is plotted in green (panel E) with all three concentrations showing an increased 
amount of activity, with the relative activity increasing by roughly 250, 900 and 1800% for 
1.2, 2.4 and 4.8 µM. The 3T protein increases the rate of refolding by roughly 300, 600 and 
1200% when compared to the blank for the 1.2, 2.4 and 4.8 µM. The Hsc70 variant 2Q 
(panel D) also shows a positive relationship between the rate of refolding and concentration 
of the chaperone, but unlike Hsc70 variants 2T and 3T this relationship is not linear. At 1.2 
µM there is no discernible additional refolding activity when compared to the blank. At 2.4 
µM there is a 400% increase in the rate of refolding relative to the blank, which is increased 
again at 4.8 µM to a 1200% increase in the rate of refolding. This data suggests that 2Q does 
not increase the rate of refolding in a linear fashion as doubling the concentration from 2.4 
to 4.8 µM leads to 3 times the activity. The last Hsc70 variant 3Q (panel B), showed a 
different response to all of the other Hsc70 variants with the chaperone both inhibiting and 
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enhancing protein refolding, depending on the concentration of the protein. At 1.2 µM the 
luminescence of the refolding assay is diminished when compared to the blank, with 
approximately 2/3 of the inherent refolding activity supressed. At higher concentrations, the 
Hsc70 3Q shows the opposite effect with both the 2.4 and 4.8 µM refolding assays showing 
increased activity when compared to the blank. At 2.4 µM the protein refolding activity is 
double when compared to the blank and at 4.8 µM the refolding activity is further increased 
to 3 times that of the blank.  
To compare the relative refolding rates all variants were assayed in unison and compared to 
wildtype Hsc70 to avoid any extra variation brought about by external factors (temperature, 
humidity, age of reagents etc.). Due to the different activities of each variant at different 
concentrations the concentration used for the overall comparison was at 2.4 µM (Figure 23) 
as each variant was active at that concentration and at 4.8 µM some variants showed no 
additional activity. Assays were run at 1.2 and 4.8 µM concentrations as well to get an 
overall indication of the activity of each variant (Appendix 1, panel A and B). The data from 
this experiment indicates that the Hsc70 variants used in FRET experimentation all had 
approximately 30% (ranged from 28-34%) of the activity of wild type Hsc70 and that Hsc70 
2C had approximately 15% of the activity.  This shows that although the function is reduced, 
it is not completely removed through the variations made to the protein.  The activity of each 
variant matches those in previous experiments suggesting that the activity of each variant is 
consistent at each concentration. One interesting aspect of the results is that the all of the 
assays appear to have increased rate of refolding at the end of the time points measured, 
which may relate to the fact the none of the variants reached the plateau during the individual 







Figure 22 Luciferase refolding assays using Hsc70 variants. Figure 17 shows the change in 
luminescence over time for luciferase refolding assays using Hsc70 variants 2C (black, panel A), 3Q 
(yellow, panel B), 3T (red, panel C), 2Q (brown, panel D) and 2T (green, panel E). The 0 µM blank is 
shown in blue for each graph, and the three concentrations of 1.2, 2.4 and 4.8 µM plotted with 
circles, triangles and squares respectively. In panel D the blank may not be visible as it overlaps 








Figure 23 Comparison of Hsc70 variants to wild type. Panel (A) shows luminescence vs time for 
refolding assays using wild type Hsc70 or one of the Hsc70 variants, all at 2.4 µM concentration. 
The 6 plots use the same colour scheme as Figure 17; Wild type = blue, 2C = black, 2T = green, 2Q 





4.4 Functionality of fluorescently labelled protein 
The last step of determining protein functionality is to test that the protein variants are still 
active after being labelled with the fluorescent dyes. DnaK variant KE 
(C16S/K321C/E430C) showed the ability to refold denatured luciferase as well as a FRET 
response to change in the bound nucleotide. It has been shown that KE has refolding activity 
prior to the addition of the Alexa Fluor dyes so the labelled protein was tested to ensure there 
was no loss of function due to the labelling process (Figure 24). The labelled KE shows a 
different refolding response to the unlabelled KE, but still showed an increase in refolding 
activity as the concentration increases. In the unlabelled KE sample the increased rate of 
refolding occurs throughout the assay, with increased activity from addition of the chaperone 
throughout the linear phase of the graph and then an increase in the final amount of refolded 
protein at the plateau. The labelled sample behaves differently as at all three concentrations, 
there is an initial retardation in the rate of refolding with all three concentrations 
experiencing a decrease in refolding activity for the first 10 minutes of the reaction. The 
amount of inhibition of activity increases at higher concentrations, with a greater decrease 
in luminescence at each time point up until the linear phase. The concentration of the labelled 
KE protein does not affect the duration of the lag effect only the significance of it with the 
1 µM concentration having a ~20% decrease in activity whilst the 2 and 4 µM concentrations 
having a ~50% and ~66% decreased inactivity respectively.  After 10 and 20 minutes the 
refolding assays that have labelled KE start to show an increased rate of refolding which is 
dependent on concentration. The increase in luminescence when compared to the wild type 
is relatively linear, with the 1, 2 and 4 µM showing an increase in activity when compared 
to the blank of ~20, 30 and 60% respectively. The unlabelled KE showed a 360% increase 
in function at 2 µM concentration so this data indicates the labelling protocol further reduces 













Figure 24 Luciferase refolding assay of fluorescently labelled variant. Shows luminescence vs time 
for luciferase refolding assay using DnaK variant KE (C16S/K321C/E430C) with Alexa Fluor dyes 
attached (Same protein from Figure 12, panel C). The labelled KE is shown in red at 1, 2 and 4 µM 





Chapter 5 Discussion  
5.1 Purification of DnaK and Hsc70 protein variants 
In this study four functional protein variants of both the bacterial DnaK and of the human 
Hsc70 were purified and tested. Each of the DnaK variants were purified using the three-
step purification protocol designed for the purification of overexpressed wild type DnaK. A 
modified version of the original purification protocol was used to separate the Hsc70 
variants with a change being made to the DEAE ion exchange chromatography. 
Expression of the DnaK and Hsc70 variants occurred in two different cell lines, BB1553 
and BB1553 DE3, both of which are deficient in wild type DnaK. The BB1553 plasmid was 
used to express and purify and was originally constructed by Montgomery (Montgomery et 
al., 1999), with the plasmid containing a tac promoter upstream of the DnaK gene. The 
plasmid also contained an ampicillin resistance gene and a gene for lacIq, allowing for 
repression as well as induction by IPTG. The Hsc70 variants were expressed in BB1553 
DE3 cells from plasmids with a T7 promoter but did not contain the lacIq. Due to the lack 
of wild type DnaK these both of cell lines are vulnerable to heat damage so are grown at a 
28°C and heat shocked at 37°C compared to the 37°C and 42°C for wild type E. coli cells. 
The BB1553 DE3 cells grow significantly slower than the BB1553 cells and do not reach 
the same overall cell density after overnight incubation. This decrease in cell viability and 
growth is coupled with the decreased expression when using the T7 IPTG inducible 
promoter rather than the IPTG promoter. All of these changes lead to a substantial decrease 
in the overall amount of protein available for purification.  
Purification of the DnaK protein variants occurred the same way as the wild type protein, 
with no variations to the original protocol. Each protein purification produced 1-2 mg of 
protein per gram of cell pellet, with no major contaminants or significant degradation, as 
can be seen in Figure 8. The purification of the Hsc70 protein variants using a linear elution 
gradient on the DEAE ion exchange column ended with a single contaminant, L-
tryptophanase, which constituted approximately 1/3 of the total protein (Figure 9). When 
examining the chromatograms and gels from the purification it was clear that the L-
tryptophanase eluted from the DEAE column at a lower salt concentration but that the 
elution peak overlapped with the Hsc70 elution peak. To separate out the two proteins whilst 
retaining as much Hsc70 as possible an isocratic step was introduced at a salt concentration 
that would divide the two proteins into separate peaks. This step effectively removed the L-
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tryptophanase from the Hsc70 containing fractions without diminishing the overall Hsc70 
yield. Due to the large difference in expression and cell density the total yield from the DnaK 
purification, it is not clear if the contamination in the Hsc70 purification with L-
tryptophanase is due to the change in expression vector or due to DnaK eluting at a slightly 
higher salt concentration than the Hsc70 (roughly 25 mS.cm-1 compared to 20 mS.cm-1) 
Due to the sparse number of tryptophan residues in both Hsc70 and DnaK, estimating protein 
concentration by measuring A280 nm with the Nanodrop spectrophotometer is not 
particularly reliable, with values gathered through densitometry or spectrophotometrically 
differing significantly. For example in the purification of DnaK variant 
(C15S/K321C/E430C) the final purified and concentrated protein product was estimated by 
A280 to be 0.5 mg.mL
-1. As the purification had appeared promising up until that point, the 
protein was run as a dilution series on a SDS-PAGE gel (Figure 9) to determine the protein 
concentration. When compared to the known concentration of the molecular weight ladder 
of 500 ng per band the DnaK KE is clearly more concentrated than the ladder in the undiluted 
lane, with too much protein being present to calculate concentration. When comparing 
concentrations of protein bands in the serial dilution the protein the 500 ng band is most 
similar to the 1/32 and 1/64 concentrations indicating that the protein concentration is at 
least 16 mg.mL-1, 32 times higher than the concentration estimated by A280.  This is due to 
the low number of aromatic residues present in DnaK and Hsc70 which can be hidden in the 
structure leading to lower estimations of concentration.  
5.2 FRET experiments 
Cysteines residues were introduced onto surface residues of the substrate binding domain 
and the nucleotide binding domain in places that would allow for the greatest change in 
intramolecular distance while not affecting the protein function. The change in 
intramolecular distance is tracked through the addition of a donor and acceptor fluorescent 
dye, AF488 and AF594 onto the introduced cysteine residues which can be used for FRET 
experiments. The distance is tracked through a form of energy transfer from the donor dye 
(AF 488) to the acceptor dye (AF 594) which changes the efficiency of transfer depending 
on the distance between them. FRET, or Fӧrster Resonance energy transfer, occurs when a 
donor chromophore is excited and transfers its energy to an acceptor chromophore through 
non-radiative dipole-dipole coupling (Helms, 2008). The efficiency of this energy transfer 








where E is the efficiency of the transfer, r is the distance between the donor and acceptor 
and R0 is the distance at which the energy transfer efficiency is 50% which is known as the 
Fӧrster radius.   
The labelling process was originally carried out using TCEP as the reductant following the 
protocol used previously in the lab by David Rogowski, however stoichiometric analysis of 
TCEP labelled samples after removal of free dye via desalting chromatography (Table 1) 
indicated that almost none of the dye was binding to the protein. To improve the labelling 
efficiency the reductant was changed to DTT as TCEP had been reported as a problem in 
the literature, not only competing with the conjugation reaction but also eluting with the 65 
kDa protein bovine serum albumin (BSA) over a desalting column (Shafer et al., 2000). This 
poses a potential problem for the labelling protocol as the reaction is very sensitive to 
concentration, with a 1:1 ratio of reduced protein to donor dye required for optimal 
conditions. Assuming the 65 kDa BSA behaves the same way over a desalting column as 
the 70 kDa chaperone protein the TCEP will coelute with DnaK/Hsc70 leading to 
competition for dye in later stages of the protocol. To test the effect of each reductant on 
labelling efficiency both reductants were added in excess to separate reactions to reduce the 
surface cysteines on the protein and the elution volumes were measured for the protein and 
each reductant. The reduced protein is eluted over 1000 µL from the NAP-5 column whilst 
TCEP begins eluting halfway through this elution whilst DTT only began eluting in the final 
drop of the 1000 µL test (Rutledge, 2016). This finding was used to modify the labelling 
protocol with the reductant changed to DTT and the elution volume decreased from 1.0 mL 
to 0.9 mL to avoid any contamination from DTT. This meant that there was a ~10% loss of 
protein however the labelling efficiency was drastically improved.  
After the protein has been separated from the DTT the reduced cysteine residues then 
allowing the maleimide on the AlexaFluor dyes to bind forming thioester bonds. During 
labelling the donor dye, AF488 is added first at equimolar concentrations, which is why this 
step is sensitive to removal of the reductant. The maleimide group will react with any 
reductant that is present in the solution so ideally only fully reduced proteins will be present 
in the solution. The amount of protein labelled with AF488 and AF594 relative to the total 
labelled with AF488 is the key ratio for ensemble FRET experiments. This is because the 
donor fluorophore (AF 488) is excited in the FRET experiments so all unlabelled protein or 
those bound with only AF594 will not respond to the excitation. The stoichiometric analysis 
indicated that when TCEP was used only 8% of the protein labelled with AF488 also had 
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AF594 whilst when DTT was used then up to 60% of the protein labelled with AF488 also 
had AF594. This means that we can expect the majority of the observable protein after 
excitation at 488 nm will have the corresponding AF594, which strengthens the analysis of 
the FRET response. 
Each of the variants for DnaK and Hsc70 were analysed via ensemble FRET for their 
response to different nucleotides. Labelling efficiency was sufficient to observe a change in 
FRET efficiency in response to nucleotide binding state for some of the variants tested, while 
others showed no FRET response. Of the 8 variants, only DnaK variant KE 
(C15S/K321C/E430C) and Hsc70 variant 3T (E318C/T427C/C603S) showed a change in 
FRET efficiency in ensemble FRET experiments. For both Hsc70 3T and DnaK KE there is 
a change in FRET efficiency from ~0.10 in the nucleotide free state to ~0.20 in the ATP 
bound state, which indicates a decrease in the distance between the two fluorophores. There 
are a number of potential reasons why some of the variants showed no change in FRET after 
the introduction of different nucleotides. The first reason is that the conformational shift 
between nucleotide dependent states does not change the FRET efficiency of the variant. 
The second reason that could explain there being no change in FRET efficiency is that the 
protein is no longer able to undergo a conformational shift in response to nucleotide binding. 
This means that the protein is no longer active and has either lost the ability to bind and 
respond to nucleotides or that it is not changing conformation as expected. Whether the 
protein has lost its functionality can be determined by the luciferase refolding assays while 
conformational shift can be assessed by limited proteolysis. The results of the limited 
proteolysis analysis showed that there was no discernible difference between any of the 
variants and the wild type protein (Rutledge, 2016). This implies that each of the variants 
undergo a conformational shift when ATP or ADP is bound however this conformational 
shift is not detected in the FRET experiments. Another possibility for the lack of FRET 
response is that the AlexaFluor dyes are quenched in either of the conformational states 
which will prevent FRET from occurring. This could be due to a change in the 
conformational shift, interactions with other parts of the protein or being in a different 
rotational orientation to the predicted state. After the mutations and modifications are made 
to the wild type protein different subdomains of the protein may behave differently leading 
to changes in the way the conformational shift occurs. The rotational state of the residue is 
also very important as the accessibility of the cysteine residue is important for labelling. If 
the cysteine residue is not facing the surface of the protein it will be difficult to access and 
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therefore there will be a decrease in labelling efficiency. In some of the variants there was 
an apparent quenching effect, with the emission from the donor peak reduced without a 
corresponding increase in the acceptor peak (Figure 17). This quenching effect of the 
517 nm emission could be explained by a conformational shift into an unfavourable 
environment. The last major reason which could contribute to variants not producing 
functional FRET pairs is that the introduced cysteines are not in suitable locations for 
measuring changes in distance between the domains. Due to the sigmoidal sensitivity to 
distance of FRET if the two AlexaFluor dyes are too far apart or too close then there may be 
no change in FRET even if a conformational shift does occur. Alternatively, the distance 
between the two dyes may not change after the conformational shift occurs, which would 
indicate that the protein variant does not behave the same way as the wild type protein and 
would not be a suitable model for dynamic studies. 
 Because there is no crystal structure for the full length Hsc70 protein in the ADP or ATP 
state the protein sequence was modelled onto the two DnaK models used 2KHO and 4B9Q. 
The cysteine variants which had been designed for DnaK were then modelled onto the Hsc70 
sequence so that both DnaK and Hsc70 had equivalent mutations. The location and 
orientation of the mutated residues were matched as closely as possible so that the DnaK 
and Hsc70 variants could be analysed in tandem. The DnaK variant KE and the equivalent 
Hsc70 variant 3T were the only two mutants to show a change in FRET efficiency in 
response to the nucleotide state. When comparing the no nucleotide to the ATP bound states 
there is a significant decrease in the 520 nm emission peak and a subsequent increase in the 
620 nm emission peak, which corresponds to FRET from the donor to acceptor dye. The fact 
that equivalent variant pairs from DnaK and Hsc70 both showed a FRET response to a 
change in nucleotide state helps to verify that the observed result is due to a conformational 
shift upon nucleotide binding and not some artefactual effect of the mutations.  
5.3 Luciferase refolding assays 
Each DnaK and Hsc70 variant had previously been examined by Malcolm Rutledge (another 
member of the Wilbanks lab) on its ability to undergo conformational change with the 
protein undergoing limited proteolysis in different nucleotide state. He found that there was 
no significant difference in any of the variants when compared to the wild type protein 
function. This confirmed that the protein variants still underwent a conformational shift in 
response to nucleotide response. However, the protein refolding activity of the chaperones 
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had not been assayed. To test the function of each protein variant luciferase refolding assays 
were performed with each variant compared to the wild type protein and to the intrinsic rate 
of refolding. 
Previously in the lab there had been difficulty in consistently getting reproducible results for 
DnaK refolding assays so modifications were made to the original assay. Due to the large 
errors produced by the inconsistent data, comparing rates of refolding became very 
inconclusive and meaningful comparison between mutants and their rates of refolding was 
unreliable. By shifting the assay into a single continuous assay the rate of refolding as well 
as the shape of the refolding curve can be more easily interpreted than in the end point assay 
used previously. In the end point assay, denatured luciferase is refolded in a reaction mix 
and at different time points some of the reaction mix is removed and tested for its 
luminescent activity. Because the refolding buffer and the reaction buffer differ and there is 
a physical transfer of the luciferase protein from one reaction to another generating a 
refolding curve is difficult. Due to the number of alterations to the original protocol, 
changing the refolding buffer and combining the two reactions into a single pot assay the 
assay was tested to ensure the reaction showed the same properties as previous studies. 
Using various concentrations of wildtype DnaK, the sensitivity to changes in protein 
refolding activity was tested, several controls were also tested to ensure that the reaction was 
sensitive to the same parameters as both protocols (Wisen and Gestwicki, 2008, Groemping 
and Reinstein, 2005). Both of these protocols had shown that the rate of refolding increased 
linearly with higher protein concentrations leading to increased rate of refolding. This linear 
response is useful for analysis as it enables the refolding rate of each variant to be calculated 
as a relative efficiency compared to the wild type.  
To test the sensitivity of the protocol three concentrations, 0.75, 1.5 and 3.0 µM 
concentrations of wildtype DnaK were assayed, and as seen in Figure 18 the rate of refolding 
responded linearly to increase in DnaK concentration. The dependence of the rate of 
refolding on cochaperones DnaJ and GrpE was also tested to make sure that the reaction was 
still sensitive to both of these molecules (Figure 19).  The results showed that GrpE was 
essential for the full functioning of the refolding activity with the reaction decreasing to 25% 
of its activity when the GrpE was removed. The results also showed that DnaJ plays a very 
important role in the full functioning of wild type DnaK with the rate of refolding dropping 
to just above the intrinsic rate of refolding. With both cochaperones present the refolding 
activity is roughly 30 times relative to the intrinsic rate of refolding, but with no DnaJ present 
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the difference in the rate of refolding is hard to discern. To better evaluate this the effect of 
DnaK alone was tested in a separate assay (panel D). In this test, there was only a 50% 
increase in activity for the 3.0 µM concentration and only a 10% increase for the 1.5 µM 
concentration with the 0.75 µM having no additional refolding activity. DnaJ role in the 
DnaK cycle is to bind unfolded proteins and then bind to DnaK which causes DnaK to 
hydrolyse ATP (Gething and Sambrook, 1992), so the decrease in activity may be due to the 
protein being unable to bind the unfolded protein rather than reducing the ability to refold 
bound protein. Two other tests were conducted as background experiments to test other 
parameters of the reaction to make sure that the assay is testing the rate of refolding by the 
DnaK chaperone. The DnaJ protein was tested for any refolding activity to ensure that the 
blank was measuring the intrinsic rate of refolding only. The results showed that at the 
concentration used in the refolding assays DnaJ had no effect on the rate of refolding, which 
indicates that the blank shows only the intrinsic rate of refolding. Another test was to see 
how long was sufficient for denaturation of the luciferase protein. The luciferase protein was 
typically denatured for 15-30 minutes, the shortest denaturation time that was test was a 
period of 2 minutes. This denaturation time proved sufficient to remove the luminescent 
ability of all the protein, allowing for a detection of different rates of refolding. All of the 
data gathered matches the expected trends and results indicating that the single pot 
continuous assay is a valid method of detecting changes in luciferase refolding activity.  
Each of the DnaK variants were analysed to see how much refolding activity each variant 
had compared to both the wildtype rate of refolding and the intrinsic refolding rate of the 
luciferase. Each variant was measured at 0.5, 1.0 and 2.0 µM concentration to assess the 
relationship between concentration and the rate of refolding. For three of the variants KE, 
NE and NR the results indicated that there is not a linear dependence on concentration with 
both the 0.5 µM and the 1.0 µM providing very slight increase in the rate of refolding 
whereas the 2.0 µM concentration showed a substantial increase in activity. At the 2.0 µM 
all three of these variants showed a dramatic increase in activity which suggests that there 
is some cooperative effect occurring. This could indicate multiple DnaK molecules binding 
to each unfolded polypeptide sequence. Previous studies have shown that multiple Hsp70 
proteins can bind to the same polypeptide chain to help fold the protein (Kellner et al., 2014) 
as well as the DnaK protein forming oligomers in solution (Bertelsen et al., 2009 and Shi et 
al., 1996). For these variants concentration of chaperone may be important as DnaK forms 
monomers, dimers and higher molecular mass oligomers depending on DnaK concentration 
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(Schӧnfeld et al., 1995). If these variants only function as high molecular mass oligomers or 
when multiple molecules are bound to each denatured luciferase molecule then the relative 
activity will be low until the critical concertation is reached.  DnaK variant KR showed a 
different refolding response with both the 0.5 and 1.0 µM concentrations showing increased 
rates of refolding when compared to the intrinsic rate of refolding however there was no 
additional activity observed when the concentration was increased to 2.0 µM. The 
concentration of luciferase in the assay is ~320 nM so if this variant works as a monomer or 
dimer increasing the concentration above 1.0 µM might not increase the rate of reaction as 
it is already at a greater concentration than the substrate. Two of the variants KR and NE 
also indicated a lag phase before refolding activity was observed. This may have been due 
to environmental conditions, with the reaction possibly needing to reach 25°C before 
refolding activity begins. It may also be related to the turnover of the protein being 
diminished with each cycle taking longer leading to an initial lag phase.  
To get a comparison of each DnaK variant to the wildtype protein all the variants were 
analysed in a single experiment along with wildtype DnaK (Figure 21). GrpE was omitted 
from this reaction so that each of the DnaK variants could be compared to the Hsc70 variants 
which will respond to DnaJ stimulation but will not interact with GrpE (Terada et al., 1997). 
At this concentration, all four variants display additional refolding activity when compared 
to the intrinsic rate of refolding and appear to all display a constant linear increase in activity 
with no lag phase or plateau affect. The variant NE showed no decrease in activity when 
compared to the wildtype DnaK over the 20 minutes assayed. The other three variants KE, 
KR and NR all showed diminished rates of refolding activity with the KE and NR showing 
roughly 20% of the additional refolding activity of wildtype DnaK and KR showing roughly 
40% of the additional refolding activity. Because this reaction does not contain GrpE there 
are a number of differences between these results and those gathered in the individual assays. 
One of the most major changes is the removal of the lag phase from the KR and NE mutants 
which now show a constant linear increase in activity. The results from this assay and the 
individual experiment suggests that each of the four DnaK variants all have refolding 
activity but the efficiency of the refolding activity compared to wildtype DnaK may differ 
depending on the concentration. Because of the concentration of both the denatured 
luciferase (320 nM) and the DnaK variants (>500 nM) it is difficult to determine whether 
each variant works at a fraction of the rate of the wild type protein or if only a fraction of 
the variant protein are functionally active. 
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Each of the Hsc70 variants were also analysed at different concentrations in individual 
assays and in a comparative assay. Due to the Hsc70 protein having reduced function 
without the presence of NEF the concentration of chaperone was increased to 1.2, 2.4 and 
4.8 µM for each assay. Hsc70 variant 2C was tested as all of the variants used in the FRET 
experiments carried this common mutation and this showed that the variant has increased 
activity relative to the blank. The results showed that at 1.2 and 2.4 µM the chaperone had 
increased refolding activity but there was no additional increase in activity at 4.8 µM. This 
result is similar to that seen in DnaK variant KR and may suggest that the variant 2C works 
as a monomer so further increases in concentration will not increase the rate of reaction. 
When analysing the Hsc70 variants, three (2Q, 2T and 3T) showed a constant increase in 
refolding rate with each increase in chaperone concentration. Both 2T and 3T showed an 
almost linear response to protein concentration with twice as much chaperone leading to 
roughly double the rate of refolding. The variant 2Q also showed a positive response to 
protein concentration, however this increase was not linear. This suggests that 2Q may 
function as monomer or dimer but the rate of reaction increases if it cooperates with other 
Hsc70 2Q molecules. The Hsc70 variant 3Q showed different response to all of the other 
chaperones assayed, with a constant decrease in activity at the lowest concentration then an 
increase in refolding activity at the two higher concentrations. This change in activity is 
different to the lag phase observed in some of the other variants as it only affects the lowest 
concentration and is a constant decrease in the amount of refolding observed. The current 
working hypothesis developed to explain this data is that the chaperone can bind to and 
sequester the protein as an extended polypeptide when in solution as a monomer but requires 
the formation of the higher molecular mass oligomeric state before it becomes active. By 
sequestering the protein as an extended polypeptide, it will prevent the fraction of the protein 
which intrinsically refold. 
A comparative assay was performed to compare all of the variants to wildtype Hsc70 
refolding activity at all three concentrations used in the individual assays. Figure 23 shows 
the results of the 2.4 µM concentration assay and indicates that each of the variants used in 
the FRET experiment had approximately the same activity relative to the wildtype protein. 
All four had roughly 30% (ranging from 28-34%) of the total activity for the wildtype assay, 
while the Hsc70 variant 2C had only 15% of the overall rate of refolding. The results from 
this experiment and the individual assays suggest that each of the Hsc70 variants have 
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protein refolding activity, although it is reduced when compared to the wild type activity 
and varies depending on concentration.  
The final luciferase assay was with DnaK variant KE labelled with both Alexa Fluor dyes 
attached to test whether labelling affected the refolding function of the protein. The results 
from this experiment showed that there is an initial lag phase which reduces the rate of 
refolding, with the higher concentrations leading to greater decreases in activity. This 
reduction of function and then the subsequent increase in refolding activity during the linear 
phase both show a relatively linear dependence on protein concentration. These data suggest 
that the protein may have a longer rate of turnover for a single reaction, with the luciferase 
protein bound by the labelled KE chaperone taking longer to refold than the intrinsic rate. 
Because only a certain percentage of the denatured protein will refold without assistance the 
assays containing the labelled KE eventually refold more protein than the blank leading to 
increased rates of reaction. This shows that the protein is still functionally active but the rate 
of reaction is further reduced by the labelling process.  
5.4 Conclusions and future directions 
In this study four DnaK and Hsc70 variants proteins were purified and analysed for FRET 
analysis to monitor the conformational change the chaperone protein undergoes in response 
to nucleotide state. A modification was made to the purification protocol of Hsc70 variants 
to remove a contaminating protein, L-tryptophanase, with an isocratic step added to the 
DEAE ion exchange elution gradient. Each variant was labelled with Alexa Fluor dyes using 
the reductant DTT and the FRET response in relation to nucleotide state was tested. Only 
Hsc70 variant 3T and DnaK variant KE showed any change in FRET in response to 
nucleotide state, showing an increase from an efficiency of 0.10 in the nucleotide free state 
to ~0.20 in the ATP bound state.   
For luciferase refolding a new continuous assay was developed which was able to detect 
changes in wildtype DnaK concentration and was sensitive to the presence of cochaperones 
DnaJ and GrpE. Using this new protocol, the rates of refolding activity of the 4 DnaK and 4 
Hsc70 variants was analysed at 3 different concentrations in individual assays as well as in 
a comparative assay.  The results from both of these experiments showed that all of the 
variant chaperones provided additional refolding activity to the assays increasing the amount 
of refolded luciferase protein, however this activity is concentration dependent with some 
72 
 
variants showing limited activity until a critical concentration is reached. The results 
indicated that each of the protein variants were functionally active.  
The results from the luciferase refolding assay and the FRET experiment exemplify some 
of the differences between DnaK and Hsc70. In the FRET experiments the two variants 
which exhibit changes in FRET efficiency have equivalent mutation suggesting that DnaK 
structures used to model the Hsc70 structure worked effectively. The luciferase refolding 
assays showed very different results with three of the Hsc70 variants showing a linear 
relationship between protein concentration and the rate of refolding. For the DnaK none of 
the variants exhibited a linear relationship between concentration and protein refolding, with 
three of them exhibiting a substantial increase in refolding activity at the highest 
concentration of 2.0 µM. This suggests that the refolding activity of the two chaperone 
proteins may differ with Hsc70 working as a monomer whilst DnaK requiring the formation 
of oligomeric states. 
The goal of this experiment was to identify a Hsc70 variant which was capable of reporting 
a conformational shift in response to nucleotide change. The variant Hsc70 3T showed a 
change in FRET efficiency in response to the nucleotide present and also showed protein 
refolding activity indicating that the protein is still functional. This variant can be used for 
future experiments to report conformational shifts within the cell, working with reporter 
other fluorescently labelled reporter proteins with known folding deficiencies. For future 
experimental work changing the expression system for Hsc70 purification from the BB1553 
DE3 plasmid to the BB1553 plasmid may lead to greater quantities of Hsc70 as it express 
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